
1. Inhibition of HIV1 protease L10I/L63P/A71V/G73S/I84V/L90M mutant
Source: ChEMBL
Protein Target: Pol polyprotein
Substance BioActivity: 9 Active, 1 Activity <= 1 nM, 9 Activity <= 1 µM, 9 Tested
AID: 274382

2. Inhibition of HIV1 protease D30N/L63P/N88D mutant
Source: ChEMBL
Protein Target: Pol polyprotein
Substance BioActivity: 9 Active, 9 Activity <= 1 nM, 9 Activity <= 1 µM, 9 Tested
AID: 274381

3. Inhibition of HIV1 protease L10I/G48V/I54V/L63P/V82A mutant
Source: ChEMBL
Protein Target: Pol polyprotein
Substance BioActivity: 9 Active, 4 Activity <= 1 nM, 9 Activity <= 1 µM, 9 Tested
AID: 274380

4. Inhibition of wild type HIV1 protease Q7K mutant
Source: ChEMBL
Protein Target: Pol polyprotein
Substance BioActivity: 42 Active, 29 Activity <= 1 nM, 42 Activity <= 1 µM, 42 Tested
AID: 274379

5. In vitro inhibition of recombinant HIV-1 protease expressed in Escherichia coli strain D1210
Source: ChEMBL
Protein Target: Pol polyprotein
Substance BioActivity: 2 Active, 9 Tested
AID: 162182

6. Tested for inhibition of synthetic HIV-1 protease by using fluorometric assay
Source: ChEMBL
Protein Target: Pol polyprotein
Substance BioActivity: 17 Active, 1 Activity <= 1 nM, 15 Activity <= 1 µM, 17 Tested
AID: 160606

7. Tested for inhibition of synthetic HIV-1 protease by using fluorometric assay
Source: ChEMBL
Protein Target: Pol polyprotein
Substance BioActivity: 13 Active, 5 Activity <= 1 nM, 13 Activity <= 1 µM, 13 Tested
AID: 82800

8. Inhibitory constant against HIV-1 protease
Source: ChEMBL
Protein Target: Pol polyprotein
Substance BioActivity: 3 Active, 2 Activity <= 1 nM, 3 Activity <= 1 µM, 3 Tested
AID: 160781

9. Inhibition of HIV-1 protease
Source: ChEMBL
Protein Target: Pol polyprotein
Substance BioActivity: 118 Active, 62 Activity <= 1 nM, 113 Activity <= 1 µM, 118 Tested
AID: 160292

10. Inhibition of virion associated RT activity (90% decrease) relative to untreated, infected control on MT2 cells infected with HIV-1 237288 strain
Source: ChEMBL
Protein Target: Pol polyprotein
Substance BioActivity: 1 Active, 1 Activity <= 1 µM, 1 Tested
AID: 199087

11. Inhibition of virion associated RT activity relative to untreated, infected control in PBMC cells infected with HIV-1 237288 strain
Source: ChEMBL
Protein Target: Pol polyprotein
Substance BioActivity: 1 Active, 1 Activity <= 1 µM, 1 Tested
AID: 199086

12. Inhibition of virion associated RT activity (90% decrease) relative to untreated, infected control on MT2 cells infected with HIV-2 strain (ROD)
Source: ChEMBL
Protein Target: Pol polyprotein
Substance BioActivity: 2 Active, 1 Activity <= 1 µM, 2 Tested
AID: 199085

13. Inhibition of virion associated RT activity (90% decrease) relative to untreated, infected control on MT2 cells infected with HIV-1 237288 strain
Source: ChEMBL
Protein Target: Pol polyprotein
Substance BioActivity: 1 Active, 1 Activity <= 1 µM, 1 Tested
AID: 199084

14. Inhibition of virion associated RT activity (90% decrease) relative to untreated, infected control in PBMC cells infected with HIV-1 237288 strain
Source: ChEMBL
Protein Target: Pol polyprotein
Substance BioActivity: 1 Active, 1 Activity <= 1 µM, 1 Tested
AID: 199083

15. Inhibition of virion associated RT activity (90% decrease) relative to untreated, infected control in MT2 cells infected with HIV-1 237288 strain
Source: ChEMBL
Protein Target: Pol polyprotein
Substance BioActivity: 2 Active, 2 Activity <= 1 µM, 2 Tested
AID: 199082

16. Inhibition of virion associated RT activity relative to untreated, infected control in cord blood mononuclear cells (CBMC) infected with HIV -1 TC354 strain
Source: ChEMBL
Protein Target: Pol polyprotein
Substance BioActivity: 4 Active, 4 Activity <= 1 µM, 4 Tested
AID: 199081

17. Inhibition of virion associated RT activity relative to untreated, infected control in PBMC cells infected with HIV-1 237288 strain
Source: ChEMBL
Protein Target: Pol polyprotein
Substance BioActivity: 3 Active, 3 Activity <= 1 µM, 3 Tested
AID: 199080

18. Inhibition of virion associated RT activity relative to untreated, infected control in MT2 cells of HIV-1 237288 strain
Source: ChEMBL
Protein Target: Pol polyprotein
Substance BioActivity: 1 Active, 1 Activity <= 1 µM, 1 Tested
AID: 199079

19. Inhibition of virion associated RT activity relative to untreated, infected control in MT2 cells infected with HIV-2 strain (ROD)
Source: ChEMBL
Protein Target: Pol polyprotein
Substance BioActivity: 2 Active, 2 Activity <= 1 µM, 2 Tested
AID: 199078

20. Inhibition of virion associated RT activity relative to untreated, infected control in MT2 cells infected with HIV-1 237288 strain
Source: ChEMBL
Protein Target: Pol polyprotein
Substance BioActivity: 3 Active, 3 Activity <= 1 µM, 3 Tested
AID: 199077

21. binding affinity towards HIV-1 Protease enzyme
Source: ChEMBL
Protein Target: Pol polyprotein
Substance BioActivity: 7 Active, 2 Activity <= 1 nM, 7 Activity <= 1 µM, 8 Tested
AID: 163484

22. Ability to inhibit HIV protease purified and refolded from Escherichia coli inclusion bodies
Source: ChEMBL
Protein Target: Pol polyprotein
Substance BioActivity: 20 Active, 16 Activity <= 1 µM, 20 Tested
AID: 162708

23. Inhibitory concentration against recombinant HIV-1 protease expressed in Escherichia coli was tested by HPLC based assay
Source: ChEMBL
Protein Target: Pol polyprotein
Substance BioActivity: 6 Active, 6 Activity <= 1 µM, 6 Tested
AID: 162529

24. Inhibitory concentration against recombinant HIV-1 111B protease expressed from Escherichia coli was tested by HPLC based assay
Source: ChEMBL
Protein Target: Pol polyprotein
Substance BioActivity: 1 Active, 1 Activity <= 1 µM, 1 Tested
AID: 162528

25. Inhibitory concentration against recombinant HIV-1 protease expressed in Escherichia coli was tested by HPLC based assay
Source: ChEMBL
Protein Target: Pol polyprotein
Substance BioActivity: 18 Active, 16 Activity <= 1 µM, 18 Tested
AID: 162368

26. binding affinity against HIV-1 protease
Source: ChEMBL
Protein Target: Pol polyprotein
Substance BioActivity: 1 Active, 1 Activity <= 1 nM, 1 Activity <= 1 µM, 1 Tested
AID: 160619

27. binding affinity against HIV-1 111B strain in protease
Source: ChEMBL
Protein Target: Pol polyprotein
Substance BioActivity: 1 Active, 1 Activity <= 1 nM, 1 Activity <= 1 µM, 1 Tested
AID: 160618

28. Binding affinity towards HIV protease
Source: ChEMBL
Protein Target: Pol polyprotein
Substance BioActivity: 6 Active, 1 Activity <= 1 nM, 6 Activity <= 1 µM, 6 Tested
AID: 160285

29. Binding affinity against HIV-1 protease.
Source: ChEMBL
Protein Target: Pol polyprotein
Substance BioActivity: 25 Active, 6 Activity <= 1 nM, 25 Activity <= 1 µM, 25 Tested
AID: 160275

30. Inhibitory potency against HIV-1 protease
Source: ChEMBL
Protein Target: Pol polyprotein
Substance BioActivity: 77 Active, 2 Activity <= 1 nM, 68 Activity <= 1 µM, 77 Tested
AID: 160774

31. Inhibition of recombinant HIV-1 protease
Source: ChEMBL
Protein Target: Pol polyprotein
Substance BioActivity: 11 Active, 7 Activity <= 1 µM, 11 Tested
AID: 160613

32. Inhibitory concentration for antiviral activity against MT-4/HIV-1IIIB cell culture
Source: ChEMBL
Protein Target: Pol polyprotein
Substance BioActivity: 13 Active, 13 Tested
AID: 83110

33. Inhibitory concentration for antiviral activity against MT-4/HIV-1IIIB cell culture.
Source: ChEMBL
Protein Target: Pol polyprotein
Substance BioActivity: 15 Active, 25 Tested
AID: 83109

34. Inhibition of HIV1 protease
Source: ChEMBL
Protein Target: Pol polyprotein
Substance BioActivity: 4 Active, 3 Activity <= 1 nM, 4 Activity <= 1 µM, 4 Tested
AID: 269303

35. Inhibitory dose against human immunodeficiency virus 1 protease
Source: ChEMBL
Protein Target: Pol polyprotein
Substance BioActivity: 1 Active, 1 Activity <= 1 µM, 1 Tested
AID: 242819

36. Inhibitory concentration against human immunodeficiency virus-1 protease; (competitive inhibitor)
Source: ChEMBL
Protein Target: Pol polyprotein
Substance BioActivity: 1 Active, 1 Tested
AID: 242450

37. Inhibitory concentration against human immunodeficiency virus-1 protease; (Dimerization inhibitor)
Source: ChEMBL
Protein Target: Pol polyprotein
Substance BioActivity: 1 Active, 1 Activity <= 1 µM, 1 Tested
AID: 242449

38. Inhibitory concentration against human immunodeficiency virus-1 protease; (Dimerization inhibitor)
Source: ChEMBL
Protein Target: Pol polyprotein
Substance BioActivity: 1 Active, 1 Activity <= 1 µM, 1 Tested
AID: 239457

39. Inhibitory concentration against human immunodeficiency virus -1 protease
Source: ChEMBL
Protein Target: Pol polyprotein
Substance BioActivity: 21 Active, 20 Activity <= 1 µM, 25 Tested
AID: 239084

40. Inhibitory activity against human immunodeficiency virus 1 protease
Source: ChEMBL
Protein Target: Pol polyprotein
Substance BioActivity: 11 Active, 3 Activity <= 1 nM, 11 Activity <= 1 µM, 11 Tested
AID: 238198

41. Inhibitory activity against HIV-1 protease was determined
Source: ChEMBL
Protein Target: Pol polyprotein
Substance BioActivity: 10 Active, 4 Activity <= 1 nM, 10 Activity <= 1 µM, 10 Tested
AID: 162206

42. Inhibitory activity against HIV-1 protease mutant was determined
Source: ChEMBL
Protein Target: Pol polyprotein
Substance BioActivity: 2 Active, 2 Activity <= 1 µM, 2 Tested
AID: 162205

43. Evaluated for the inhibition of HIV-1 Protease.
Source: ChEMBL
Protein Target: Pol polyprotein
Substance BioActivity: 18 Active, 2 Activity <= 1 µM, 19 Tested
AID: 162539

44. Inhibitory activity against HIV-1 Protease.
Source: ChEMBL
Protein Target: Pol polyprotein
Substance BioActivity: 2 Active, 1 Activity <= 1 µM, 2 Tested
AID: 162197

45. Inhibitory activity against HIV-1 protease
Source: ChEMBL
Protein Target: Pol polyprotein
Substance BioActivity: 10 Active, 1 Activity <= 1 µM, 24 Tested
AID: 162196

46. HIV Protease inhibitory activity
Source: ChEMBL
Protein Target: Pol polyprotein
Substance BioActivity: 12 Active, 12 Activity <= 1 µM, 12 Tested
AID: 160447

47. Binding affinity to inhibit the purified wild-type HIV-1 Protease
Source: ChEMBL
Protein Target: Pol polyprotein
Substance BioActivity: 17 Active, 16 Activity <= 1 nM, 17 Activity <= 1 µM, 17 Tested
AID: 160316

48. Competitive inhibitory activity against HIV-1 protease
Source: ChEMBL
Protein Target: Pol polyprotein
Substance BioActivity: 1 Active, 1 Activity <= 1 µM, 2 Tested
AID: 160783

49. Apparent inhibition constant against recombinant HIV-1 protease
Source: ChEMBL
Protein Target: Pol polyprotein
Substance BioActivity: 11 Active, 2 Activity <= 1 nM, 8 Activity <= 1 µM, 11 Tested
AID: 160611

50. In vitro inhibitory activity against biotinylated human HIV-1 protease
Source: ChEMBL
Protein Target: Pol polyprotein
Substance BioActivity: 8 Active, 1 Activity <= 1 nM, 9 Activity <= 1 µM, 10 Tested
AID: 160452

51. Inhibitory concentration against accumulation of viral p24 antigen following infection of MT-4 cells
Source: ChEMBL
Protein Target: Pol polyprotein
Substance BioActivity: 17 Active, 16 Activity <= 1 µM, 17 Tested
AID: 105206

52. Inhibition of dimerization of HIV1 protease
Source: ChEMBL
Protein Target: Pol polyprotein
Substance BioActivity: 15 Active, 10 Activity <= 1 µM, 15 Tested
AID: 281804

53. Inhibition of dimerization of HIV1 protease MDR-HM mutant
Source: ChEMBL
Protein Target: Pol polyprotein
Substance BioActivity: 1 Active, 1 Tested
AID: 266495

54. Inhibition of dimerization of HIV1 protease G48V/L90M mutant
Source: ChEMBL
Protein Target: Pol polyprotein
Substance BioActivity: 1 Active, 1 Activity <= 1 µM, 1 Tested
AID: 266494

55. Inhibition of dimerization of HIV1 protease V82A mutant
Source: ChEMBL
Protein Target: Pol polyprotein
Substance BioActivity: 1 Active, 1 Activity <= 1 µM, 1 Tested
AID: 266493

56. Inhibition of dimerization of HIV1 protease 150V mutant
Source: ChEMBL
Protein Target: Pol polyprotein
Substance BioActivity: 1 Active, 1 Activity <= 1 µM, 1 Tested
AID: 266492

57. Inhibition of dimerization of HIV1 protease D30N mutant
Source: ChEMBL
Protein Target: Pol polyprotein
Substance BioActivity: 1 Active, 1 Activity <= 1 µM, 1 Tested
AID: 266491

58. Inhibition of wild type HIV1 protease
Source: ChEMBL
Protein Target: Pol polyprotein
Substance BioActivity: 2 Active, 2 Tested
AID: 266487

59. Inhibitory activity against HIV protease
Source: ChEMBL
Protein Target: Pol polyprotein
Substance BioActivity: 9 Active, 12 Activity <= 1 µM, 12 Tested
AID: 263364

60. Inhibitory activity against isolated wild-type HIV1 protease
Source: ChEMBL
Protein Target: Pol polyprotein
Substance BioActivity: 9 Active, 2 Activity <= 1 nM, 10 Activity <= 1 µM, 10 Tested
AID: 260390

61. inhibitory concentration against HIV-1 protease from PI-resistant clinical isolate (V18)
Source: ChEMBL
Protein Target: Pol polyprotein
Substance BioActivity: 11 Active, 8 Activity <= 1 nM, 11 Activity <= 1 µM, 11 Tested
AID: 242318

62. Inhibitory concentration against human immunodeficiency virus (HIV) protease
Source: ChEMBL
Protein Target: Pol polyprotein
Substance BioActivity: 2 Active, 2 Activity <= 1 µM, 2 Tested
AID: 241986

63. Inhibitory concentration against human immunodeficiency virus protease in fluorescence assay
Source: ChEMBL
Protein Target: Pol polyprotein
Substance BioActivity: 1 Active, 1 Tested
AID: 241510

64. Inhibitory concentration against HIV-1 protease (NL4-3)
Source: ChEMBL
Protein Target: Pol polyprotein
Substance BioActivity: 17 Active, 17 Activity <= 1 nM, 17 Activity <= 1 µM, 17 Tested
AID: 241213

65. Concentration required to in inhibit HIV-1 protease by 50%
Source: ChEMBL
Protein Target: Pol polyprotein
Substance BioActivity: 2 Active, 2 Activity <= 1 µM, 2 Tested
AID: 240880

66. Binding affinity against human immunodeficiency virus (HIV) protease
Source: ChEMBL
Protein Target: Pol polyprotein
Substance BioActivity: 31 Active, 2 Activity <= 1 nM, 43 Activity <= 1 µM, 43 Tested
AID: 238959

67. Inhibition constant for human immunodeficiency virus type 1 protease
Source: ChEMBL
Protein Target: Pol polyprotein
Substance BioActivity: 27 Active, 16 Activity <= 1 nM, 25 Activity <= 1 µM, 27 Tested
AID: 238682

68. Potency to inhibit HIV-1 protease
Source: ChEMBL
Protein Target: Pol polyprotein
Substance BioActivity: 11 Active, 2 Activity <= 1 nM, 11 Activity <= 1 µM, 11 Tested
AID: 238257

69. In vitro inhibitory activity against HIV-1 Protease
Source: ChEMBL
Protein Target: Pol polyprotein
Substance BioActivity: 7 Active, 7 Tested
AID: 162184

70. HIV-1 protease inhibition.
Source: ChEMBL
Protein Target: Pol polyprotein
Substance BioActivity: 37 Active, 19 Activity <= 1 nM, 36 Activity <= 1 µM, 37 Tested
AID: 162030

71. Dimerization inhibition against HIV-1 Protease
Source: ChEMBL
Protein Target: Pol polyprotein
Substance BioActivity: 5 Active, 4 Activity <= 1 µM, 5 Tested
AID: 160627

72. Competitive inhibition against HIV-1 Protease
Source: ChEMBL
Protein Target: Pol polyprotein
Substance BioActivity: 4 Active, 1 Activity <= 1 µM, 4 Tested
AID: 160626

73. Inhibitory concentration against HIV-1 protease
Source: ChEMBL
Protein Target: Pol polyprotein
Substance BioActivity: 23 Active, 4 Activity <= 1 nM, 23 Activity <= 1 µM, 23 Tested
AID: 160481

74. Inhibitory activity against HIV-1 protease
Source: ChEMBL
Protein Target: Pol polyprotein
Substance BioActivity: 5 Active, 5 Activity <= 1 nM, 5 Activity <= 1 µM, 5 Tested
AID: 160477

75. Dissociation constant obtained by inhibition of mutant HIV-protease (V-18)
Source: ChEMBL
Protein Target: Pol polyprotein
Substance BioActivity: 4 Active, 4 Activity <= 1 µM, 4 Tested
AID: 225564

76. Dissociation constant obtained by inhibition of mutant HIV-protease (K-60)
Source: ChEMBL
Protein Target: Pol polyprotein
Substance BioActivity: 4 Active, 4 Activity <= 1 µM, 4 Tested
AID: 225563

77. Dissociation constant obtained by inhibition of mutant HIV-protease (A-44)
Source: ChEMBL
Protein Target: Pol polyprotein
Substance BioActivity: 4 Active, 4 Activity <= 1 µM, 4 Tested
AID: 225562

78. Dissociation constant obtained by inhibition of Wild-type protease
Source: ChEMBL
Protein Target: Pol polyprotein
Substance BioActivity: 4 Active, 4 Activity <= 1 nM, 4 Activity <= 1 µM, 4 Tested
AID: 219260

79. Binding affinity for HIV-1 protease enzyme was measured by using fluorescent peptide substrate
Source: ChEMBL
Protein Target: Pol polyprotein
Substance BioActivity: 47 Active, 7 Activity <= 1 nM, 46 Activity <= 1 µM, 48 Tested
AID: 163483

80. Evaluated for the inhibition of Protease
Source: ChEMBL
Protein Target: Pol polyprotein
Substance BioActivity: 1 Active, 1 Activity <= 1 µM, 1 Tested
AID: 162538

81. Inhibition of HIV-1 protease in vitro.
Source: ChEMBL
Protein Target: Pol polyprotein
Substance BioActivity: 21 Active, 21 Activity <= 1 µM, 21 Tested
AID: 162537

82. Concentration required for 95%Inhibition of Protease
Source: ChEMBL
Protein Target: Pol polyprotein
Substance BioActivity: 1 Active, 1 Activity <= 1 µM, 1 Tested
AID: 162536

83. Concentration required for 95% inhibition of Protease
Source: ChEMBL
Protein Target: Pol polyprotein
Substance BioActivity: 6 Active, 6 Activity <= 1 µM, 6 Tested
AID: 162535

84. compound was evaluated for the inhibition of HIV-1 protease
Source: ChEMBL
Protein Target: Pol polyprotein
Substance BioActivity: 2 Active, 6 Tested
AID: 162520

85. Evaluated for the inhibition of Protease
Source: ChEMBL
Protein Target: Pol polyprotein
Substance BioActivity: 1 Active, 1 Activity <= 1 nM, 1 Activity <= 1 µM, 1 Tested
AID: 162066

86. Inhibition of HIV-1 protease in vitro.
Source: ChEMBL
Protein Target: Pol polyprotein
Substance BioActivity: 21 Active, 17 Activity <= 1 nM, 21 Activity <= 1 µM, 21 Tested
AID: 162065

87. Concentration required for 50% inhibition of Protease
Source: ChEMBL
Protein Target: Pol polyprotein
Substance BioActivity: 7 Active, 6 Activity <= 1 nM, 7 Activity <= 1 µM, 7 Tested
AID: 162061

88. Inhibitory activity against HIV-1 protease expressed in Escherichia coli
Source: ChEMBL
Protein Target: Pol polyprotein
Substance BioActivity: 12 Active, 8 Activity <= 1 nM, 12 Activity <= 1 µM, 12 Tested
AID: 160470

89. Inhibitory activity against HIV-1 protease in tandem assay.
Source: ChEMBL
Protein Target: Pol polyprotein
Substance BioActivity: 35 Active, 18 Activity <= 1 nM, 36 Activity <= 1 µM, 36 Tested
AID: 160466

90. Inhibition of recombinant HIV-1 protease (NY-5)
Source: ChEMBL
Protein Target: Pol polyprotein
Substance BioActivity: 14 Active, 5 Activity <= 1 nM, 14 Activity <= 1 µM, 14 Tested
AID: 160444

91. Compound was evaluated for its binding affinity against HIV-1 protease
Source: ChEMBL
Protein Target: Pol polyprotein
Substance BioActivity: 1 Active, 1 Tested
AID: 160301

92. Inhibitory activity against HIV-1 protease
Source: ChEMBL
Protein Target: Pol polyprotein
Substance BioActivity: 40 Active, 9 Activity <= 1 nM, 42 Activity <= 1 µM, 42 Tested
AID: 162349

93. Inhibitory activity against HIV protease at pH 6.2
Source: ChEMBL
Protein Target: Pol polyprotein
Substance BioActivity: 6 Active, 6 Activity <= 1 µM, 6 Tested
AID: 162200

94. Inhibitory activity against HIV protease at pH 4.7
Source: ChEMBL
Protein Target: Pol polyprotein
Substance BioActivity: 8 Active, 8 Activity <= 1 µM, 8 Tested
AID: 162199

95. Inhibitory activity against HIV protease
Source: ChEMBL
Protein Target: Pol polyprotein
Substance BioActivity: 56 Active, 42 Activity <= 1 µM, 56 Tested
AID: 162198

96. Inhibition of HIV -1 protease
Source: ChEMBL
Protein Target: Pol polyprotein
Substance BioActivity: 5 Active, 3 Activity <= 1 µM, 6 Tested
AID: 162191

97. Antiviral activity against wild type HXB2 virus protease
Source: ChEMBL
Protein Target: Pol polyprotein
Substance BioActivity: 1 Active, 1 Activity <= 1 µM, 1 Tested
AID: 161888

98. Inhibitory activity against HIV-1 protease enzyme
Source: ChEMBL
Protein Target: Pol polyprotein
Substance BioActivity: 8 Active, 12 Activity <= 1 µM, 12 Tested
AID: 161887

99. Compound was tested for binding affinity against HIV protease
Source: ChEMBL
Protein Target: Pol polyprotein
Substance BioActivity: 1 Active, 1 Activity <= 1 nM, 1 Activity <= 1 µM, 1 Tested
AID: 161860

100. Inhibitory activity was measured against wild-type HIV-1 protease
Source: ChEMBL
Protein Target: Pol polyprotein
Substance BioActivity: 6 Active, 5 Activity <= 1 nM, 6 Activity <= 1 µM, 6 Tested
AID: 161509

101. Inhibitory activity was measured against wild-type HIV-1 protease
Source: ChEMBL
Protein Target: Pol polyprotein
Substance BioActivity: 1 Active, 1 Activity <= 1 nM, 1 Activity <= 1 µM, 1 Tested
AID: 161507

102. Inhibitory activity against HIV-1 Protease
Source: ChEMBL
Protein Target: Pol polyprotein
Substance BioActivity: 8 Active, 7 Activity <= 1 nM, 8 Activity <= 1 µM, 8 Tested
AID: 160475

103. Binding affinity against HIV-1 protease
Source: ChEMBL
Protein Target: Pol polyprotein
Substance BioActivity: 25 Active, 2 Activity <= 1 nM, 20 Activity <= 1 µM, 25 Tested
AID: 160314

104. Compound was tested for binding affinity against HIV protease
Source: ChEMBL
Protein Target: Pol polyprotein
Substance BioActivity: 1 Active, 1 Activity <= 1 µM, 1 Tested
AID: 160311

105. Binding affinity towards HIV-1 Protease
Source: ChEMBL
Protein Target: Pol polyprotein
Substance BioActivity: 3 Active, 2 Activity <= 1 µM, 3 Tested
AID: 160288

106. Antiviral activity against 460.6 clone of HXB2 mutant virus in their protease sequence
Source: ChEMBL
Protein Target: Pol polyprotein
Substance BioActivity: 1 Active, 1 Activity <= 1 µM, 1 Tested
AID: 80891

107. Antiviral activity against 460.2 clone of HXB2 mutant virus in their protease sequence
Source: ChEMBL
Protein Target: Pol polyprotein
Substance BioActivity: 1 Active, 1 Activity <= 1 µM, 1 Tested
AID: 80890

108. Inhibitory activity against HIV-1 protease
Source: ChEMBL
Protein Target: Pol polyprotein
Substance BioActivity: 33 Active, 29 Activity <= 1 µM, 33 Tested
AID: 162032

109. Inhibitory activity against HIV-1 protease
Source: ChEMBL
Protein Target: Pol polyprotein
Substance BioActivity: 36 Active, 6 Activity <= 1 µM, 43 Tested
AID: 161872

110. Inhibition of HIV-1 Protease activity
Source: ChEMBL
Protein Target: Pol polyprotein
Substance BioActivity: 13 Active, 13 Activity <= 1 nM, 13 Activity <= 1 µM, 13 Tested
AID: 161524

111. Compound was tested for inhibition of HIV-1 protease (taken from ZhangPoorman plot)
Source: ChEMBL
Protein Target: Pol polyprotein
Substance BioActivity: 1 Active, 1 Tested
AID: 82948

112. Inhibitory activity against HIV-1 protease
Source: ChEMBL
Protein Target: Pol polyprotein
Substance BioActivity: 2 Active, 2 Tested
AID: 82947

113. Compound was evaluated for in vitro inhibition of human immunodeficiency virus type 1 (HIV-1) Protease
Source: ChEMBL
Protein Target: Pol polyprotein
Substance BioActivity: 3 Active, 1 Activity <= 1 µM, 3 Tested
AID: 162031

114. Compound was evaluated for in vitro inhibition of human immunodeficiency virus type 1 (HIV-1) Protease
Source: ChEMBL
Protein Target: Pol polyprotein
Substance BioActivity: 8 Active, 4 Activity <= 1 nM, 8 Activity <= 1 µM, 8 Tested
AID: 160296

115. Compound was assayed for inhibition against HIV protease activity
Source: ChEMBL
Protein Target: Pol polyprotein
Substance BioActivity: 7 Active, 1 Activity <= 1 nM, 5 Activity <= 1 µM, 7 Tested
AID: 160293

116. Compound was assayed for inhibition against HIV protease activity
Source: ChEMBL
Protein Target: Pol polyprotein
Substance BioActivity: 1 Active, 1 Activity <= 1 nM, 1 Activity <= 1 µM, 1 Tested
AID: 82791

117. Anti-HIV-1 activity against mutant HIV-1 in MT-4 cells (mutation selected with ritonavir)
Source: ChEMBL
Protein Target: Pol polyprotein
Substance BioActivity: 21 Active, 7 Activity <= 1 µM, 23 Tested
AID: 104303

118. Anti-HIV-1 activity against mutant HIV-1 in MT-4 cells (mutation selected with nelfinavir)
Source: ChEMBL
Protein Target: Pol polyprotein
Substance BioActivity: 22 Active, 16 Activity <= 1 µM, 23 Tested
AID: 104302

119. Anti-HIV-1 activity against mutant HIV-1 in MT-4 cells (mutation selected with compound 1)
Source: ChEMBL
Protein Target: Pol polyprotein
Substance BioActivity: 22 Active, 11 Activity <= 1 µM, 23 Tested
AID: 104301

120. Inhibition of HIV1 protease
Source: ChEMBL
Protein Target: Pol polyprotein
Substance BioActivity: 14 Active, 12 Activity <= 1 µM, 16 Tested
AID: 274708

121. Inhibition of HIV1 protease I8 mutant
Source: ChEMBL
Protein Target: Pol polyprotein
Substance BioActivity: 4 Active, 1 Activity <= 1 nM, 4 Activity <= 1 µM, 4 Tested
AID: 270946

122. Inhibition of wild type HIV1 protease
Source: ChEMBL
Protein Target: Pol polyprotein
Substance BioActivity: 4 Active, 2 Activity <= 1 nM, 4 Activity <= 1 µM, 4 Tested
AID: 270945

123. Inhibition of HIV protease
Source: ChEMBL
Protein Target: Pol polyprotein
Substance BioActivity: 16 Active, 15 Activity <= 1 µM, 16 Tested
AID: 270299

124. Inhibition of HIV aspartyl protease
Source: ChEMBL
Protein Target: Pol polyprotein
Substance BioActivity: 36 Active, 27 Activity <= 1 nM, 38 Activity <= 1 µM, 38 Tested
AID: 267711

125. Displacement of [3H]GW0385 from HIV1 protease
Source: ChEMBL
Protein Target: Pol polyprotein
Substance BioActivity: 2 Active, 2 Activity <= 1 nM, 2 Activity <= 1 µM, 2 Tested
AID: 263228

126. Inhibitory activity against HIV1 protease expressed in Escherichia coli in a fluorometric assay
Source: ChEMBL
Protein Target: Pol polyprotein
Substance BioActivity: 10 Active, 9 Activity <= 1 µM, 10 Tested
AID: 257134

127. Inhibitory activity against Human immunodeficiency virus-1 protease
Source: ChEMBL
Protein Target: Pol polyprotein
Substance BioActivity: 10 Active, 1 Activity <= 1 µM, 13 Tested
AID: 241247

128. Binding activity towards Human immunodeficiency virus-1 protease
Source: ChEMBL
Protein Target: Pol polyprotein
Substance BioActivity: 3 Active, 1 Activity <= 1 µM, 6 Tested
AID: 238609

129. Binding affinity against HIV-1 protease
Source: ChEMBL
Protein Target: Pol polyprotein
Substance BioActivity: 1 Active, 1 Activity <= 1 nM, 1 Activity <= 1 µM, 2 Tested
AID: 238117

130. Tested for binding affinity against protease
Source: ChEMBL
Protein Target: Pol polyprotein
Substance BioActivity: 1 Active, 1 Activity <= 1 µM, 1 Tested
AID: 162707

131. The inhibitory concentration was evaluated for viral strains HIV-2 ROD using a HIV protease HPLC based assay.
Source: ChEMBL
Protein Target: Pol polyprotein
Substance BioActivity: 1 Active, 1 Activity <= 1 µM, 1 Tested
AID: 162518

132. The inhibitory concentration was evaluated for viral strains HIV-1 IIIB using a HIV protease HPLC based assay.
Source: ChEMBL
Protein Target: Pol polyprotein
Substance BioActivity: 1 Active, 1 Activity <= 1 µM, 1 Tested
AID: 162517

133. Activity of potent nonpeptidic inhibitor against protease
Source: ChEMBL
Protein Target: Pol polyprotein
Substance BioActivity: 59 Active, 59 Activity <= 1 µM, 59 Tested
AID: 162029

134. Inhibitory activity against HIV-1 protease
Source: ChEMBL
Protein Target: Pol polyprotein
Substance BioActivity: 10 Active, 3 Activity <= 1 nM, 10 Activity <= 1 µM, 10 Tested
AID: 160782

135. Tested for binding affinity against HIV protease
Source: ChEMBL
Protein Target: Pol polyprotein
Substance BioActivity: 17 Active, 11 Activity <= 1 nM, 17 Activity <= 1 µM, 17 Tested
AID: 160605

136. Inhibitory activity against HIV-1 protease (Escherichia coli)
Source: ChEMBL
Protein Target: Pol polyprotein
Substance BioActivity: 1 Active, 1 Activity <= 1 nM, 1 Activity <= 1 µM, 1 Tested
AID: 160469

137. Inhibitory concentration against purified recombinant HIV-1 protease using fluorogenic substrate
Source: ChEMBL
Protein Target: Pol polyprotein
Substance BioActivity: 12 Active, 12 Activity <= 1 µM, 12 Tested
AID: 162370

138. Inhibitory activity against HIV-1 protease.
Source: ChEMBL
Protein Target: Pol polyprotein
Substance BioActivity: 49 Active, 20 Activity <= 1 nM, 42 Activity <= 1 µM, 49 Tested
AID: 160770

139. Affinity against HIV protease
Source: ChEMBL
Protein Target: Pol polyprotein
Substance BioActivity: 24 Active, 22 Activity <= 1 nM, 24 Activity <= 1 µM, 24 Tested
AID: 162710

140. Inhibitory activity against HIV-1 protease
Source: ChEMBL
Protein Target: Pol polyprotein
Substance BioActivity: 4 Active, 4 Activity <= 1 µM, 4 Tested
AID: 160468

141. Inhibition of HIV protease, measured by assaying the cleavage of a fluorescent peptide substrate using HPLC
Source: ChEMBL
Protein Target: Pol polyprotein
Substance BioActivity: 26 Active, 22 Activity <= 1 nM, 26 Activity <= 1 µM, 26 Tested
AID: 160458

142. Binding affinity towards HIV protease was determined
Source: ChEMBL
Protein Target: Pol polyprotein
Substance BioActivity: 19 Active, 10 Activity <= 1 nM, 16 Activity <= 1 µM, 22 Tested
AID: 160287

143. Binding affinity against HIV-1 protease
Source: ChEMBL
Protein Target: Pol polyprotein
Substance BioActivity: 104 Active, 16 Activity <= 1 nM, 107 Activity <= 1 µM, 107 Tested
AID: 160271

144. In vitro inhibition of HIV-1 protease.
Source: ChEMBL
Protein Target: Pol polyprotein
Substance BioActivity: 15 Active, 7 Activity <= 1 µM, 21 Tested
AID: 162519

145. In vitro inhibition of HIV-1 protease
Source: ChEMBL
Protein Target: Pol polyprotein
Substance BioActivity: 33 Active, 16 Activity <= 1 nM, 31 Activity <= 1 µM, 33 Tested
AID: 162194

146. Inhibition of HIV protease
Source: ChEMBL
Protein Target: Pol polyprotein
Substance BioActivity: 12 Active, 4 Activity <= 1 nM, 11 Activity <= 1 µM, 12 Tested
AID: 162058

147. Inhibition of purified recombinant HIV-1 protease in a fluorogenic assay
Source: ChEMBL
Protein Target: Pol polyprotein
Substance BioActivity: 78 Active, 33 Activity <= 1 nM, 77 Activity <= 1 µM, 78 Tested
AID: 162051

148. Inhibition of HIV-1 protease was determined in vitro
Source: ChEMBL
Protein Target: Pol polyprotein
Substance BioActivity: 16 Active, 4 Activity <= 1 nM, 11 Activity <= 1 µM, 16 Tested
AID: 160772

149. Inhibition of HIV-1 protease in vitro.
Source: ChEMBL
Protein Target: Pol polyprotein
Substance BioActivity: 16 Active, 1 Activity <= 1 nM, 23 Activity <= 1 µM, 23 Tested
AID: 160303

150. Inhibitory activity against HIV protease in peptide cleavage assay
Source: ChEMBL
Protein Target: Pol polyprotein
Substance BioActivity: 29 Active, 14 Activity <= 1 nM, 29 Activity <= 1 µM, 29 Tested
AID: 162512

151. Inhibitory activity against HIV Protease in peptide cleavage assay
Source: ChEMBL
Protein Target: Pol polyprotein
Substance BioActivity: 16 Active, 4 Activity <= 1 nM, 15 Activity <= 1 µM, 16 Tested
AID: 162511

152. In vitro inhibition of HIV-Protease, using a peptide hydrolysis assay
Source: ChEMBL
Protein Target: Pol polyprotein
Substance BioActivity: 3 Active, 2 Activity <= 1 µM, 7 Tested
AID: 162044

153. In vitro inhibition of HIV protease, using a peptide hydrolysis assay
Source: ChEMBL
Protein Target: Pol polyprotein
Substance BioActivity: 8 Active, 2 Activity <= 1 nM, 3 Activity <= 1 µM, 8 Tested
AID: 162043

154. Inhibition constant was determined against HIV-1 protease
Source: ChEMBL
Protein Target: Pol polyprotein
Substance BioActivity: 2 Active, 1 Activity <= 1 µM, 5 Tested
AID: 160457

155. In vitro inhibition of HIV-Protease, using a peptide hydrolysis assay
Source: ChEMBL
Protein Target: Pol polyprotein
Substance BioActivity: 1 Active, 1 Activity <= 1 nM, 1 Activity <= 1 µM, 1 Tested
AID: 160310

156. Binding affinity to HIV protease
Source: ChEMBL
Protein Target: Pol polyprotein
Substance BioActivity: 27 Active, 8 Activity <= 1 nM, 27 Activity <= 1 µM, 27 Tested
AID: 160304

157. Inhibitory activity against HIV-1 Protease from wild-type NL4-3 virus
Source: ChEMBL
Protein Target: Pol polyprotein
Substance BioActivity: 6 Active, 6 Activity <= 1 nM, 6 Activity <= 1 µM, 6 Tested
AID: 161871

158. Inhibitory activity against HIV-1 Protease from PI-resistant HIV-1 (strain V-60C)
Source: ChEMBL
Protein Target: Pol polyprotein
Substance BioActivity: 6 Active, 2 Activity <= 1 nM, 6 Activity <= 1 µM, 6 Tested
AID: 161870

159. Inhibitory activity against HIV-1 Protease from PI-resistant HIV-1 (strain K-60C)
Source: ChEMBL
Protein Target: Pol polyprotein
Substance BioActivity: 6 Active, 4 Activity <= 1 nM, 6 Activity <= 1 µM, 6 Tested
AID: 161867

160. Inhibitory concentration against human immunodeficiency virus (HIV) protease
Source: ChEMBL
Protein Target: Pol polyprotein
Substance BioActivity: 5 Active, 6 Activity <= 1 µM, 6 Tested
AID: 162369

161. Inhibition of wild type HIV protease
Source: ChEMBL
Protein Target: Pol polyprotein
Substance BioActivity: 13 Active, 13 Activity <= 1 nM, 13 Activity <= 1 µM, 13 Tested
AID: 162195

162. Inhibition of HIV protease of HIV V-18C mutant strain
Source: ChEMBL
Protein Target: Pol polyprotein
Substance BioActivity: 13 Active, 9 Activity <= 1 nM, 13 Activity <= 1 µM, 13 Tested
AID: 162193

163. Inhibition of HIV protease of HIV K-60C mutant strain
Source: ChEMBL
Protein Target: Pol polyprotein
Substance BioActivity: 13 Active, 8 Activity <= 1 nM, 13 Activity <= 1 µM, 13 Tested
AID: 162192

164. Inhibitory concentration against wild-type human immunodeficiency virus (HIV-WT) protease
Source: ChEMBL
Protein Target: Pol polyprotein
Substance BioActivity: 5 Active, 4 Activity <= 1 µM, 7 Tested
AID: 83429

165. Inhibitory activity against HIV-1 protease
Source: ChEMBL
Protein Target: Pol polyprotein
Substance BioActivity: 8 Active, 3 Activity <= 1 nM, 7 Activity <= 1 µM, 8 Tested
AID: 82796

166. Inhibitory activity against HIV-1 protease
Source: ChEMBL
Protein Target: Pol polyprotein
Substance BioActivity: 1 Active, 1 Tested
AID: 82766

167. Compound was evaluated for the inhibitory activity towards HIV protease
Source: ChEMBL
Protein Target: Pol polyprotein
Substance BioActivity: 7 Active, 7 Activity <= 1 µM, 7 Tested
AID: 162041

168. Tested in vitro for HIV protease (PR) binding affinity
Source: ChEMBL
Protein Target: Pol polyprotein
Substance BioActivity: 22 Active, 2 Activity <= 1 nM, 22 Activity <= 1 µM, 22 Tested
AID: 162386

169. Inhibitory activity against HIV-1 Protease was determined
Source: ChEMBL
Protein Target: Pol polyprotein
Substance BioActivity: 2 Active, 5 Tested
AID: 162204

170. Inhibition of HIV-1 protease by fluorogenic substrate assay
Source: ChEMBL
Protein Target: Pol polyprotein
Substance BioActivity: 11 Active, 12 Tested
AID: 162050

171. Compound was tested for the inhibition of HIV-1 protease by assaying the cleavage of a fluorescent peptide using HPLC
Source: ChEMBL
Protein Target: Pol polyprotein
Substance BioActivity: 9 Active, 4 Activity <= 1 µM, 9 Tested
AID: 160443

172. Compound was tested for binding affinity against HIV protease
Source: ChEMBL
Protein Target: Pol polyprotein
Substance BioActivity: 1 Active, 1 Activity <= 1 nM, 1 Activity <= 1 µM, 1 Tested
AID: 160312

173. Inhibition of HIV protease
Source: ChEMBL
Protein Target: Pol polyprotein
Substance BioActivity: 12 Active, 9 Activity <= 1 nM, 12 Activity <= 1 µM, 13 Tested
AID: 160300

174. Compound was evaluated for binding affinity against HIV protease
Source: ChEMBL
Protein Target: Pol polyprotein
Substance BioActivity: 7 Active, 8 Activity <= 1 µM, 10 Tested
AID: 160294

175. Binding affinity was evaluated for competitive inhibition of HIV-1 Protease
Source: ChEMBL
Protein Target: Pol polyprotein
Substance BioActivity: 1 Active, 1 Tested
AID: 160291

176. The compound was evaluated for inhibition of HIV protease
Source: ChEMBL
Protein Target: Pol polyprotein
Substance BioActivity: 8 Active, 7 Activity <= 1 nM, 8 Activity <= 1 µM, 8 Tested
AID: 82915

177. Compound was evaluated for inhibition of HIV protease
Source: ChEMBL
Protein Target: Pol polyprotein
Substance BioActivity: 1 Active, 1 Activity <= 1 nM, 1 Activity <= 1 µM, 1 Tested
AID: 82913

178. Inhibitory activity was evaluated against human immunodeficiency virus type 1(HIV-1) protease at pH 4.7
Source: ChEMBL
Protein Target: Pol polyprotein
Substance BioActivity: 2 Active, 2 Activity <= 1 nM, 2 Activity <= 1 µM, 2 Tested
AID: 82797

179. Inhibitory activity was evaluated against human immunodeficiency virus type 1(HIV-1) protease at pH 6.2
Source: ChEMBL
Protein Target: Pol polyprotein
Substance BioActivity: 7 Active, 2 Activity <= 1 nM, 7 Activity <= 1 µM, 7 Tested
AID: 82773

180. Inhibitory concentration against human immunodeficiency virus type 1(HIV-1) protease at pH 4.7
Source: ChEMBL
Protein Target: Pol polyprotein
Substance BioActivity: 12 Active, 12 Activity <= 1 µM, 12 Tested
AID: 82772

181. Antiviral activity potency was assessed by measuring effect on the accumulation of viral RNA transcripts 3 days after infection of MT-2 cells with HIV-1RF
Source: ChEMBL
Protein Target: Pol polyprotein
Substance BioActivity: 19 Active, 5 Activity <= 1 nM, 15 Activity <= 1 µM, 19 Tested
AID: 244073

182. Tested for inhibitor binding of wild-type HIV PR
Source: ChEMBL
Protein Target: Pol polyprotein
Substance BioActivity: 2 Active, 2 Activity <= 1 nM, 2 Activity <= 1 µM, 2 Tested
AID: 82946

183. Tested for inhibitor binding of Val82Ala mutant of HIV PR
Source: ChEMBL
Protein Target: Pol polyprotein
Substance BioActivity: 1 Active, 1 Activity <= 1 nM, 1 Activity <= 1 µM, 1 Tested
AID: 82945

184. Tested for inhibitor binding of D25N/V82A mutant of HIV PR
Source: ChEMBL
Protein Target: Pol polyprotein
Substance BioActivity: 1 Active, 1 Activity <= 1 nM, 1 Activity <= 1 µM, 1 Tested
AID: 82944

185. In vitro inhibition of HIV-1.
Source: ChEMBL
Protein Target: Pol polyprotein
Substance BioActivity: 20 Active, 14 Activity <= 1 µM, 21 Tested
AID: 162516

186. Inhibitory concentration against drug-resistant HIV(V82F) mutant
Source: ChEMBL
Protein Target: Pol polyprotein
Substance BioActivity: 1 Active, 1 Activity <= 1 µM, 1 Tested
AID: 83384

187. Inhibitory concentration against TL3-resistant HIV(V771) mutant
Source: ChEMBL
Protein Target: Pol polyprotein
Substance BioActivity: 1 Active, 1 Activity <= 1 µM, 1 Tested
AID: 83378

188. Inhibitory concentration against TL3-resistant HIV(M461) mutant
Source: ChEMBL
Protein Target: Pol polyprotein
Substance BioActivity: 1 Active, 1 Activity <= 1 µM, 1 Tested
AID: 83375

189. Inhibitory concentration against TL3-resistant HIV(L63P) mutant
Source: ChEMBL
Protein Target: Pol polyprotein
Substance BioActivity: 1 Active, 1 Activity <= 1 µM, 1 Tested
AID: 83372

190. Inhibitory concentration against TL3-resistant HIV(L241) mutant
Source: ChEMBL
Protein Target: Pol polyprotein
Substance BioActivity: 1 Active, 1 Activity <= 1 µM, 1 Tested
AID: 83369

191. Inhibitory concentration against drug-resistant HIV(G48V) mutant
Source: ChEMBL
Protein Target: Pol polyprotein
Substance BioActivity: 1 Active, 1 Activity <= 1 µM, 1 Tested
AID: 83366

192. Inhibitory concentration against TL3-resistant HIV(F53L) mutant
Source: ChEMBL
Protein Target: Pol polyprotein
Substance BioActivity: 1 Active, 1 Activity <= 1 µM, 1 Tested
AID: 83242

193. Inhibitory concentration against human immunodeficiency virus-1 protease
Source: ChEMBL
Protein Target: Pol polyprotein
Substance BioActivity: 15 Active, 5 Activity <= 1 µM, 18 Tested
AID: 241933

194. Inhibitory concentration against HIV-1 Protease
Source: ChEMBL
Protein Target: Pol polyprotein
Substance BioActivity: 1 Active, 1 Tested
AID: 162540

195. HIV Protease inhibitory activity
Source: ChEMBL
Protein Target: Pol polyprotein
Substance BioActivity: 4 Active, 5 Activity <= 1 µM, 12 Tested
AID: 162067

196. Inhibitory activity against HIV-I protease.
Source: ChEMBL
Protein Target: Pol polyprotein
Substance BioActivity: 31 Active, 31 Activity <= 1 µM, 31 Tested
AID: 160614

197. Antiviral activity against HIV-I infected H9 cells
Source: ChEMBL
Protein Target: Pol polyprotein
Substance BioActivity: 13 Active, 16 Tested
AID: 78930

198. Inhibitory activity against human immunodeficiency virus protease (HIVP) using protease inhibition assay
Source: ChEMBL
Protein Target: Pol polyprotein
Substance BioActivity: 8 Active, 9 Activity <= 1 µM, 9 Tested
AID: 82902

199. Inhibition of wild type HIV1 recombinant aspartic protease
Source: ChEMBL
Protein Target: Pol polyprotein
Substance BioActivity: 3 Active, 1 Activity <= 1 nM, 3 Activity <= 1 µM, 3 Tested
AID: 320685

200. Inhibition of HIV1 protease
Source: ChEMBL
Protein Target: Pol polyprotein
Substance BioActivity: 14 Active, 1 Activity <= 1 µM, 15 Tested
AID: 281802

201. Inhibition of dimerization of HIV1 protease ANAM-11 mutant
Source: ChEMBL
Protein Target: Pol polyprotein
Substance BioActivity: 1 Active, 1 Activity <= 1 µM, 1 Tested
AID: 266496

202. Inhibition of wild type HIV1 protease dimerization
Source: ChEMBL
Protein Target: Pol polyprotein
Substance BioActivity: 2 Active, 2 Activity <= 1 µM, 2 Tested
AID: 266488

203. Inhibition of HIV1 protease
Source: ChEMBL
Protein Target: Pol polyprotein
Substance BioActivity: 22 Active, 22 Activity <= 1 µM, 22 Tested
AID: 262351

204. Binding affinity to HIV1 protease L90M
Source: ChEMBL
Protein Target: Pol polyprotein
Substance BioActivity: 2 Active, 2 Activity <= 1 nM, 2 Activity <= 1 µM, 2 Tested
AID: 260518

205. Binding affinity to HIV1 protease I84V
Source: ChEMBL
Protein Target: Pol polyprotein
Substance BioActivity: 2 Active, 2 Activity <= 1 µM, 2 Tested
AID: 260517

206. Binding affinity to HIV1 protease V82A
Source: ChEMBL
Protein Target: Pol polyprotein
Substance BioActivity: 2 Active, 1 Activity <= 1 nM, 2 Activity <= 1 µM, 2 Tested
AID: 260516

207. Binding affinity to HIV1 protease I50V
Source: ChEMBL
Protein Target: Pol polyprotein
Substance BioActivity: 2 Active, 2 Activity <= 1 µM, 2 Tested
AID: 260515

208. Binding affinity to HIV1 protease D30N
Source: ChEMBL
Protein Target: Pol polyprotein
Substance BioActivity: 2 Active, 2 Activity <= 1 µM, 2 Tested
AID: 260514

209. Binding affinity to HIV1 protease
Source: ChEMBL
Protein Target: Pol polyprotein
Substance BioActivity: 2 Active, 2 Activity <= 1 nM, 2 Activity <= 1 µM, 2 Tested
AID: 260513

210. Inhibitory activity against HIV protease
Source: ChEMBL
Protein Target: Pol polyprotein
Substance BioActivity: 15 Active, 15 Activity <= 1 nM, 15 Activity <= 1 µM, 15 Tested
AID: 257496

211. Inhibitory concentration against HIV-1 protease expressed in Escherichia coli upon incubation in pH 5.5 buffer containing Abz-Thr-Ile-p-nitrophenylalanine-Phe-Gln-Arg-NH2
Source: ChEMBL
Protein Target: Pol polyprotein
Substance BioActivity: 7 Active, 4 Activity <= 1 µM, 9 Tested
AID: 255105

212. Binding affinity for HIV-1 protease expressed in Escherichia coli upon incubation in pH 5.5 buffer containing Abz-Thr-Ile-p-nitrophenylalanine-Phe-Gln-Arg-NH2
Source: ChEMBL
Protein Target: Pol polyprotein
Substance BioActivity: 8 Active, 1 Activity <= 1 nM, 4 Activity <= 1 µM, 10 Tested
AID: 254530

213. Antiviral activity against HIV protease in absence of human serum
Source: ChEMBL
Protein Target: Pol polyprotein
Substance BioActivity: 1 Active, 1 Activity <= 1 µM, 1 Tested
AID: 246061

214. Antiviral activity against HIV protease
Source: ChEMBL
Protein Target: Pol polyprotein
Substance BioActivity: 1 Active, 1 Activity <= 1 µM, 1 Tested
AID: 246029

215. Inhibitory concentration against human immunodeficiency virus 1 protease in MT-4 cells
Source: ChEMBL
Protein Target: Pol polyprotein
Substance BioActivity: 4 Active, 4 Activity <= 1 µM, 4 Tested
AID: 241288

216. Potency to inhibit HIV-1 protease
Source: ChEMBL
Protein Target: Pol polyprotein
Substance BioActivity: 19 Active, 16 Activity <= 1 nM, 19 Activity <= 1 µM, 19 Tested
AID: 238258

217. Inhibition constant for HIV aspartyl protease
Source: ChEMBL
Protein Target: Pol polyprotein
Substance BioActivity: 38 Active, 40 Activity <= 1 µM, 40 Tested
AID: 238237

218. Inhibition constant against HIV Protease
Source: ChEMBL
Protein Target: Pol polyprotein
Substance BioActivity: 17 Active, 16 Activity <= 1 nM, 17 Activity <= 1 µM, 17 Tested
AID: 238230

219. Inhibition constant against HIV-1 protease
Source: ChEMBL
Protein Target: Pol polyprotein
Substance BioActivity: 23 Active, 16 Activity <= 1 nM, 23 Activity <= 1 µM, 23 Tested
AID: 238179

220. Tested for inhibition of HIV protease
Source: ChEMBL
Protein Target: Pol polyprotein
Substance BioActivity: 3 Active, 2 Activity <= 1 nM, 3 Activity <= 1 µM, 3 Tested
AID: 238177

221. Binding affinity for human immunodeficiency virus type 1 protease
Source: ChEMBL
Protein Target: Pol polyprotein
Substance BioActivity: 26 Active, 5 Activity <= 1 nM, 24 Activity <= 1 µM, 27 Tested
AID: 238043

222. Inhibitory activity against HIV-I protease was determined
Source: ChEMBL
Protein Target: Pol polyprotein
Substance BioActivity: 1 Active, 1 Activity <= 1 µM, 1 Tested
AID: 162356

223. Inhibitory activity against HIV-I protease was determined
Source: ChEMBL
Protein Target: Pol polyprotein
Substance BioActivity: 2 Active, 1 Activity <= 1 nM, 2 Activity <= 1 µM, 2 Tested
AID: 160479

224. Equilibrium constant for the interaction between inhibitor and HIV-1 Protease
Source: ChEMBL
Protein Target: Pol polyprotein
Substance BioActivity: 38 Active, 4 Activity <= 1 nM, 34 Activity <= 1 µM, 39 Tested
AID: 162706

225. Inhibitory activity against HIV-1 protease
Source: ChEMBL
Protein Target: Pol polyprotein
Substance BioActivity: 36 Active, 2 Activity <= 1 nM, 36 Activity <= 1 µM, 36 Tested
AID: 162202

226. Concentration required to inhibit HIV-1 protease cleavage by 50%.
Source: ChEMBL
Protein Target: Pol polyprotein
Substance BioActivity: 5 Active, 1 Activity <= 1 nM, 1 Activity <= 1 µM, 5 Tested
AID: 162064

227. Inhibitory activity against HIV-1 protease
Source: ChEMBL
Protein Target: Pol polyprotein
Substance BioActivity: 60 Active, 29 Activity <= 1 nM, 60 Activity <= 1 µM, 60 Tested
AID: 160776

228. Inhibitory activity against HIV protease expressed in Escherichia coli
Source: ChEMBL
Protein Target: Pol polyprotein
Substance BioActivity: 12 Active, 5 Activity <= 1 nM, 12 Activity <= 1 µM, 12 Tested
AID: 160462

229. Inhibition constant against HIV-1 Protease (Remeasured value)
Source: ChEMBL
Protein Target: Pol polyprotein
Substance BioActivity: 5 Active, 2 Activity <= 1 nM, 5 Activity <= 1 µM, 5 Tested
AID: 160456

230. Inhibition constant against HIV-1 Protease
Source: ChEMBL
Protein Target: Pol polyprotein
Substance BioActivity: 45 Active, 16 Activity <= 1 nM, 41 Activity <= 1 µM, 52 Tested
AID: 160455

231. inhibitory activity against purified HIV-1 protease in a standardized spectrophotometric assay expressed in Escherichia coli
Source: ChEMBL
Protein Target: Pol polyprotein
Substance BioActivity: 2 Active, 1 Activity <= 1 µM, 2 Tested
AID: 162521

232. Inhibition of human immunodeficiency virus type 1 (HIV-1) protease enzyme.
Source: ChEMBL
Protein Target: Pol polyprotein
Substance BioActivity: 36 Active, 15 Activity <= 1 nM, 33 Activity <= 1 µM, 36 Tested
AID: 160775

233. Inhibitory activity against HIV-1 protease.
Source: ChEMBL
Protein Target: Pol polyprotein
Substance BioActivity: 32 Active, 16 Activity <= 1 nM, 31 Activity <= 1 µM, 32 Tested
AID: 160771

234. Inhibitory activity against purified HIV-1 protease expressed in Escherichia coli in sensitive fluorometric assay
Source: ChEMBL
Protein Target: Pol polyprotein
Substance BioActivity: 11 Active, 3 Activity <= 1 nM, 8 Activity <= 1 µM, 11 Tested
AID: 160620

235. Inhibitory activity against HIV-1 Protease expressed in Escherichia coli
Source: ChEMBL
Protein Target: Pol polyprotein
Substance BioActivity: 7 Active, 7 Activity <= 1 µM, 7 Tested
AID: 160465

236. Compound was tested for binding affinity against HIV-1 protease.
Source: ChEMBL
Protein Target: Pol polyprotein
Substance BioActivity: 9 Active, 5 Activity <= 1 µM, 9 Tested
AID: 160315

237. Inhibition of HIV-1 protease in a cell culture assay using HIV-1 IIIB infected H9 cells.
Source: ChEMBL
Protein Target: Pol polyprotein
Substance BioActivity: 28 Active, 18 Activity <= 1 µM, 32 Tested
AID: 78951

238. Inhibition of HIV-1 protease in a cell culture assay using HIV-1 IIIB infected H9 cells.
Source: ChEMBL
Protein Target: Pol polyprotein
Substance BioActivity: 28 Active, 25 Activity <= 1 µM, 32 Tested
AID: 78939

239. Ability to inhibit purified recombinant HIV-1 protease.
Source: ChEMBL
Protein Target: Pol polyprotein
Substance BioActivity: 1 Active, 1 Activity <= 1 nM, 1 Activity <= 1 µM, 1 Tested
AID: 162709

240. Inhibitory activity against HIV-1 protease cleavage of [V-S-Q-N-(beta-naphthylalanine)-P-I-V)
Source: ChEMBL
Protein Target: Pol polyprotein
Substance BioActivity: 30 Active, 30 Activity <= 1 µM, 30 Tested
AID: 162357

241. In vivo antiviral activity (IC50) against HIV-1 protease.
Source: ChEMBL
Protein Target: Pol polyprotein
Substance BioActivity: 31 Active, 31 Activity <= 1 µM, 32 Tested
AID: 162053

242. Ability to inhibit purified recombinant HIV-1 protease.
Source: ChEMBL
Protein Target: Pol polyprotein
Substance BioActivity: 17 Active, 14 Activity <= 1 µM, 18 Tested
AID: 162027

243. Inhibitory activity against HIV-1 protease
Source: ChEMBL
Protein Target: Pol polyprotein
Substance BioActivity: 67 Active, 13 Activity <= 1 nM, 61 Activity <= 1 µM, 67 Tested
AID: 161876

244. Inhibitory activity against HIV protease
Source: ChEMBL
Protein Target: Pol polyprotein
Substance BioActivity: 47 Active, 6 Activity <= 1 nM, 42 Activity <= 1 µM, 47 Tested
AID: 160473

245. Compound was tested for binding affinity against HIV-1 Protease
Source: ChEMBL
Protein Target: Pol polyprotein
Substance BioActivity: 24 Active, 18 Activity <= 1 nM, 24 Activity <= 1 µM, 24 Tested
AID: 160313

246. Binding affinity against HIV protease
Source: ChEMBL
Protein Target: Pol polyprotein
Substance BioActivity: 25 Active, 6 Activity <= 1 nM, 21 Activity <= 1 µM, 25 Tested
AID: 160280

247. Binding affinity against HIV-1 protease
Source: ChEMBL
Protein Target: Pol polyprotein
Substance BioActivity: 7 Active, 2 Activity <= 1 nM, 7 Activity <= 1 µM, 7 Tested
AID: 160270

248. Binding affinity against HIV -1 protease
Source: ChEMBL
Protein Target: Pol polyprotein
Substance BioActivity: 6 Active, 4 Activity <= 1 µM, 6 Tested
AID: 162711

249. Evaluated for the inhibition of HIV protease
Source: ChEMBL
Protein Target: Pol polyprotein
Substance BioActivity: 19 Active, 12 Activity <= 1 nM, 19 Activity <= 1 µM, 19 Tested
AID: 162036

250. Inhibitory activity against HIV-1 Protease
Source: ChEMBL
Protein Target: Pol polyprotein
Substance BioActivity: 30 Active, 26 Activity <= 1 µM, 30 Tested
AID: 160773

251. Tested for inhibitory concentration against HIV-1 protease in experiment 2
Source: ChEMBL
Protein Target: Pol polyprotein
Substance BioActivity: 1 Active, 1 Activity <= 1 nM, 1 Activity <= 1 µM, 1 Tested
AID: 162381

252. Tested for inhibitory concentration against HIV-1 protease
Source: ChEMBL
Protein Target: Pol polyprotein
Substance BioActivity: 19 Active, 13 Activity <= 1 nM, 19 Activity <= 1 µM, 19 Tested
AID: 162380

253. In vitro enzyme inhibitory activity against HIV-1 protease.
Source: ChEMBL
Protein Target: Pol polyprotein
Substance BioActivity: 1 Active, 1 Activity <= 1 nM, 1 Activity <= 1 µM, 1 Tested
AID: 162181

254. In vitro enzyme inhibitory activity against HIV-1 protease.
Source: ChEMBL
Protein Target: Pol polyprotein
Substance BioActivity: 20 Active, 16 Activity <= 1 nM, 20 Activity <= 1 µM, 20 Tested
AID: 162180

255. Inhibition of HIV-1 protease
Source: ChEMBL
Protein Target: Pol polyprotein
Substance BioActivity: 39 Active, 33 Activity <= 1 nM, 39 Activity <= 1 µM, 40 Tested
AID: 161728

256. Inhibitory activity against HIV-1 protease (V-18C strain)
Source: ChEMBL
Protein Target: Pol polyprotein
Substance BioActivity: 3 Active, 1 Activity <= 1 nM, 3 Activity <= 1 µM, 3 Tested
AID: 162355

257. In vitro inhibition of HIV-1 protease (NL4-3 strain).
Source: ChEMBL
Protein Target: Pol polyprotein
Substance BioActivity: 21 Active, 20 Activity <= 1 nM, 21 Activity <= 1 µM, 21 Tested
AID: 162352

258. Inhibitory activity against HIV-1 protease (K-60C strain)
Source: ChEMBL
Protein Target: Pol polyprotein
Substance BioActivity: 3 Active, 1 Activity <= 1 nM, 3 Activity <= 1 µM, 3 Tested
AID: 162351

259. Inhibitory activity of compound against HIV-1 protease in wild type NL4-3 virus
Source: ChEMBL
Protein Target: Pol polyprotein
Substance BioActivity: 10 Active, 10 Activity <= 1 nM, 10 Activity <= 1 µM, 10 Tested
AID: 162217

260. Inhibitory activity of compound against HIV-1 protease in HIV-1 (V-18C) strain
Source: ChEMBL
Protein Target: Pol polyprotein
Substance BioActivity: 10 Active, 5 Activity <= 1 nM, 10 Activity <= 1 µM, 10 Tested
AID: 162216

261. Inhibitory activity against HIV-1 Protease
Source: ChEMBL
Protein Target: Pol polyprotein
Substance BioActivity: 9 Active, 9 Activity <= 1 nM, 9 Activity <= 1 µM, 9 Tested
AID: 162201

262. Evaluated for inhibition of Protease from the crude plate mixture
Source: ChEMBL
Protein Target: Pol polyprotein
Substance BioActivity: 2 Active, 2 Tested
AID: 161731

263. Evaluated for inhibition of Protease after resynthesis and purification
Source: ChEMBL
Protein Target: Pol polyprotein
Substance BioActivity: 3 Active, 3 Tested
AID: 161730

264. Evaluated for inhibition of Protease after CLND/MS correction from the crude mixture
Source: ChEMBL
Protein Target: Pol polyprotein
Substance BioActivity: 3 Active, 3 Tested
AID: 161729

265. Inhibitory activity of compound against HIV-1 protease in HIV-1 (K-60C) strain
Source: ChEMBL
Protein Target: Pol polyprotein
Substance BioActivity: 1 Active, 1 Activity <= 1 nM, 1 Activity <= 1 µM, 1 Tested
AID: 82764

266. Inhibitory concentration required to inhibit cleavage of a substrate by thewild-type HIV-1 protease enzyme
Source: ChEMBL
Protein Target: Pol polyprotein
Substance BioActivity: 1 Active, 1 Activity <= 1 nM, 1 Activity <= 1 µM, 1 Tested
AID: 223674

267. Inhibitory concentration against wild-type HIV-1 protease
Source: ChEMBL
Protein Target: Pol polyprotein
Substance BioActivity: 12 Active, 8 Activity <= 1 nM, 12 Activity <= 1 µM, 12 Tested
AID: 162374

268. Inhibitory concentration required to inhibit cleavage of a substrate by the wild-type HIV-1 Protease
Source: ChEMBL
Protein Target: Pol polyprotein
Substance BioActivity: 4 Active, 3 Activity <= 1 nM, 4 Activity <= 1 µM, 4 Tested
AID: 162373

269. In vitro inhibitory activity against wild type HIV-1 protease
Source: ChEMBL
Protein Target: Pol polyprotein
Substance BioActivity: 15 Active, 5 Activity <= 1 nM, 15 Activity <= 1 µM, 15 Tested
AID: 162188

270. In vitro inhibitory activity against mutant HIV-1 (A-44)protease
Source: ChEMBL
Protein Target: Pol polyprotein
Substance BioActivity: 15 Active, 1 Activity <= 1 nM, 15 Activity <= 1 µM, 15 Tested
AID: 162187

271. The compound was tested for its inhibition against HIV-1 protease
Source: ChEMBL
Protein Target: Pol polyprotein
Substance BioActivity: 6 Active, 2 Activity <= 1 nM, 5 Activity <= 1 µM, 6 Tested
AID: 82803

272. Inhibitory concentration required to inhibit cleavage of a substrate by the wild-type HIV-1 protease enzyme
Source: ChEMBL
Protein Target: Pol polyprotein
Substance BioActivity: 1 Active, 1 Activity <= 1 nM, 1 Activity <= 1 µM, 1 Tested
AID: 82776

273. Compound was tested for its inhibitory potency against human immunodeficiency virus -1 (HIV-1 protease); In house preparation
Source: ChEMBL
Protein Target: Pol polyprotein
Substance BioActivity: 1 Active, 1 Activity <= 1 nM, 1 Activity <= 1 µM, 1 Tested
AID: 82624

274. Compound was tested for its inhibitory potency against human immunodeficiency virus -1 (HIV-1 protease)
Source: ChEMBL
Protein Target: Pol polyprotein
Substance BioActivity: 17 Active, 1 Activity <= 1 nM, 23 Activity <= 1 µM, 23 Tested
AID: 82623

275. Inhibitory activity of compound against HIV-1 aspartyl protease.
Source: ChEMBL
Protein Target: Pol polyprotein
Substance BioActivity: 51 Active, 30 Activity <= 1 nM, 51 Activity <= 1 µM, 51 Tested
AID: 39382

276. Compound was evaluated for the inhibition of HIV-1 protease
Source: ChEMBL
Protein Target: Pol polyprotein
Substance BioActivity: 10 Active, 7 Activity <= 1 µM, 10 Tested
AID: 162037

277. Inhibitory concentration of compound resulting in half-maximal inactivation of HIV-1 protease
Source: ChEMBL
Protein Target: Pol polyprotein
Substance BioActivity: 1 Active, 1 Tested
AID: 160630

278. Inhibitory activity against HIV protease
Source: ChEMBL
Protein Target: Pol polyprotein
Substance BioActivity: 3 Active, 3 Activity <= 1 nM, 3 Activity <= 1 µM, 3 Tested
AID: 160461

279. Compound was tested for inhibition of HIV-1 protease by a dissociative mechanism
Source: ChEMBL
Protein Target: Pol polyprotein
Substance BioActivity: 1 Active, 1 Tested
AID: 82949

280. In vitro inhibitory concentration to prevent cleavage of a substrate by the protease enzyme
Source: ChEMBL
Protein Target: Pol polyprotein
Substance BioActivity: 3 Active, 1 Activity <= 1 nM, 3 Activity <= 1 µM, 3 Tested
AID: 162186

281. Compound was tested for 50% irreversible inhibition of HIV-1 protease; value ranges from 10-50
Source: ChEMBL
Protein Target: Pol polyprotein
Substance BioActivity: 3 Active, 3 Activity <= 1 µM, 3 Tested
AID: 162046

282. Inhibitory activity against HIV-1 IIIB/CEM-SS protease
Source: ChEMBL
Protein Target: Pol polyprotein
Substance BioActivity: 1 Active, 1 Activity <= 1 µM, 1 Tested
AID: 161890

283. Inhibitory activity against HIV-1 protease
Source: ChEMBL
Protein Target: Pol polyprotein
Substance BioActivity: 12 Active, 12 Activity <= 1 µM, 12 Tested
AID: 160442

284. Inhibitory activity against HIV protease
Source: ChEMBL
Protein Target: Pol polyprotein
Substance BioActivity: 27 Active, 21 Activity <= 1 nM, 27 Activity <= 1 µM, 27 Tested
AID: 160441

285. Binding affinity for HIV protease
Source: ChEMBL
Protein Target: Pol polyprotein
Substance BioActivity: 11 Active, 11 Activity <= 1 nM, 11 Activity <= 1 µM, 11 Tested
AID: 160436

286. Inhibition of human immunodeficiency virus (HIV) protease isolated enzyme assay
Source: ChEMBL
Protein Target: Pol polyprotein
Substance BioActivity: 13 Active, 11 Activity <= 1 nM, 13 Activity <= 1 µM, 13 Tested
AID: 160297

287. Binding affinity against HIV-1 protease was determined
Source: ChEMBL
Protein Target: Pol polyprotein
Substance BioActivity: 4 Active, 2 Activity <= 1 µM, 8 Tested
AID: 160278

288. HIV protease inhibition.
Source: ChEMBL
Protein Target: Pol polyprotein
Substance BioActivity: 17 Active, 12 Activity <= 1 nM, 17 Activity <= 1 µM, 17 Tested
AID: 82912

289. Binding affinity to HIV-1 protease was determined
Source: ChEMBL
Protein Target: Pol polyprotein
Substance BioActivity: 24 Active, 1 Activity <= 1 nM, 23 Activity <= 1 µM, 24 Tested
AID: 82790

290. Inhibitory concentration against multi-PI resistant D545701 in MT-4 cell lines(fold range = 28)
Source: ChEMBL
Protein Target: Pol polyprotein
Substance BioActivity: 1 Active, 1 Activity <= 1 µM, 1 Tested
AID: 248117

291. Inhibitory concentration against multi-PI resistant D545701 in MT-4 cell lines(fold range = 23)
Source: ChEMBL
Protein Target: Pol polyprotein
Substance BioActivity: 1 Active, 1 Activity <= 1 µM, 1 Tested
AID: 248116

292. Inhibitory concentration against multi-PI resistant EP13 in MT-4 cell lines(fold range = 33)
Source: ChEMBL
Protein Target: Pol polyprotein
Substance BioActivity: 1 Active, 1 Activity <= 1 µM, 1 Tested
AID: 248049

293. Inhibitory concentration against multi-PI resistant EP13 in MT-4 cell lines(fold range = 26)
Source: ChEMBL
Protein Target: Pol polyprotein
Substance BioActivity: 1 Active, 1 Activity <= 1 µM, 1 Tested
AID: 248048

294. Inhibitory concentration against multi-PI resistant EP13 in MT-4 cell lines(fold range = 24)
Source: ChEMBL
Protein Target: Pol polyprotein
Substance BioActivity: 1 Active, 1 Activity <= 1 µM, 1 Tested
AID: 248047

295. Inhibitory concentration against multi-PI resistant EP13 in MT-4 cell lines(fold range = 9)
Source: ChEMBL
Protein Target: Pol polyprotein
Substance BioActivity: 1 Active, 1 Activity <= 1 µM, 1 Tested
AID: 248032

296. Inhibitory concentration against multi-PI resistant EP13 in MT-4 cell lines(fold range = 8)
Source: ChEMBL
Protein Target: Pol polyprotein
Substance BioActivity: 1 Active, 1 Activity <= 1 µM, 1 Tested
AID: 248031

297. Inhibitory concentration against multi-PI resistant EP13 in MT-4 cell lines(fold range = 3)
Source: ChEMBL
Protein Target: Pol polyprotein
Substance BioActivity: 1 Active, 1 Activity <= 1 µM, 1 Tested
AID: 248030

298. Anti-HIV-1 activity against Wild type virus in MT-4 cells
Source: ChEMBL
Protein Target: Pol polyprotein
Substance BioActivity: 22 Active, 20 Activity <= 1 µM, 22 Tested
AID: 104312

299. Anti-HIV-1 activity against mutant HIV-1 in MT-4 cells (mutation selected with saquinavir)
Source: ChEMBL
Protein Target: Pol polyprotein
Substance BioActivity: 22 Active, 14 Activity <= 1 µM, 22 Tested
AID: 104304

300. concentration of compound required to inhibit 90% of RT production in HIV-1/MN-infected MT-2 cells.
Source: ChEMBL
Protein Target: Pol polyprotein
Substance BioActivity: 22 Active, 22 Activity <= 1 µM, 22 Tested
AID: 106913

301. Concentration required to inhibit 50% of RT production in HIV-1/MN-infected MT-2 cells.
Source: ChEMBL
Protein Target: Pol polyprotein
Substance BioActivity: 22 Active, 6 Activity <= 1 nM, 22 Activity <= 1 µM, 22 Tested
AID: 106906

302. Inhibitory activity against HIV PR in HIV-1 infected CEM-SS cell lines
Source: ChEMBL
Protein Target: Pol polyprotein
Substance BioActivity: 6 Active, 1 Activity <= 1 µM, 7 Tested
AID: 161861

303. Inhibitory activity against HIV PR in HIV-1 infected CEM-SS cell lines
Source: ChEMBL
Protein Target: Pol polyprotein
Substance BioActivity: 4 Active, 11 Tested
AID: 161733

304. In vitro inhibitory activity against HIV PR using cell viability assay at a clear dose response
Source: ChEMBL
Protein Target: Pol polyprotein
Substance BioActivity: 1 Active, 2 Tested
AID: 161732

305. Tested for inhibitory concentration against spread of HIV-1 in MT-4 human T-lymphoid cells infected with IIIb isolate
Source: ChEMBL
Protein Target: Pol polyprotein
Substance BioActivity: 12 Active, 13 Activity <= 1 µM, 13 Tested
AID: 105394

306. Tested in vitro for potential potency against PI-resistant HIV virus by A-44 mutant enzyme variant
Source: ChEMBL
Protein Target: Pol polyprotein
Substance BioActivity: 4 Active, 3 Activity <= 1 nM, 4 Activity <= 1 µM, 4 Tested
AID: 82778

307. Compound was tested for its antiviral potency against human immunodeficiency virus type 1
Source: ChEMBL
Protein Target: Pol polyprotein
Substance BioActivity: 1 Active, 1 Activity <= 1 µM, 1 Tested
AID: 81788

308. Inhibitory activity against HIV-1 IIIB in CEM-SS infected cells (Experiment 1)
Source: ChEMBL
Protein Target: Pol polyprotein
Substance BioActivity: 1 Active, 1 Activity <= 1 µM, 1 Tested
AID: 82282

309. Binding affinity against HIV-1 protease
Source: ChEMBL
Protein Target: Pol polyprotein
Substance BioActivity: 2 Active, 2 Activity <= 1 nM, 2 Activity <= 1 µM, 2 Tested
AID: 236270

310. Inhibitory activity against HIV-1 protease (Escherichia coli)
Source: ChEMBL
Protein Target: Pol polyprotein
Substance BioActivity: 5 Active, 2 Activity <= 1 nM, 5 Activity <= 1 µM, 5 Tested
AID: 160471

311. Inhibitory activity against HIV-1 protease
Source: ChEMBL
Protein Target: Pol polyprotein
Substance BioActivity: 42 Active, 41 Activity <= 1 nM, 42 Activity <= 1 µM, 42 Tested
AID: 163487

312. Binding affinity for HIV-1 protease
Source: ChEMBL
Protein Target: Pol polyprotein
Substance BioActivity: 29 Active, 28 Activity <= 1 nM, 29 Activity <= 1 µM, 29 Tested
AID: 163485

313. Inhibition of HIV-1 protease
Source: ChEMBL
Protein Target: Pol polyprotein
Substance BioActivity: 20 Active, 2 Activity <= 1 µM, 29 Tested
AID: 162038

314. Inhibitory activity against HIV-1 protease
Source: ChEMBL
Protein Target: Pol polyprotein
Substance BioActivity: 16 Active, 1 Activity <= 1 nM, 16 Activity <= 1 µM, 16 Tested
AID: 161862

315. Inhibitory concentration against Protease
Source: ChEMBL
Protein Target: Pol polyprotein
Substance BioActivity: 7 Active, 7 Tested
AID: 163481

316. Inhibitory activity against HIV-1 Protease from PI-resistant HIV-1 (strain Q-18C)
Source: ChEMBL
Protein Target: Pol polyprotein
Substance BioActivity: 5 Active, 3 Activity <= 1 nM, 5 Activity <= 1 µM, 5 Tested
AID: 161868

317. Inhibitory concentration against drug-resistant HIV(V82F) mutant protease
Source: ChEMBL
Protein Target: Pol polyprotein
Substance BioActivity: 3 Active, 3 Activity <= 1 µM, 3 Tested
AID: 83385

318. Inhibitory concentration against TL3-resistant HIV(V771) mutant protease
Source: ChEMBL
Protein Target: Pol polyprotein
Substance BioActivity: 3 Active, 3 Activity <= 1 µM, 3 Tested
AID: 83379

319. Inhibitory concentration against TL3-resistant HIV(M461) mutant protease
Source: ChEMBL
Protein Target: Pol polyprotein
Substance BioActivity: 3 Active, 3 Activity <= 1 µM, 3 Tested
AID: 83376

320. Inhibitory concentration against TL3-resistant HIV(L63P) mutant protease
Source: ChEMBL
Protein Target: Pol polyprotein
Substance BioActivity: 3 Active, 3 Activity <= 1 µM, 3 Tested
AID: 83373

321. Inhibitory concentration against TL3-resistant HIV(L241) mutant protease
Source: ChEMBL
Protein Target: Pol polyprotein
Substance BioActivity: 3 Active, 3 Activity <= 1 µM, 3 Tested
AID: 83370

322. Inhibitory concentration against drug-resistant HIV(G48V) mutant protease
Source: ChEMBL
Protein Target: Pol polyprotein
Substance BioActivity: 3 Active, 3 Activity <= 1 µM, 3 Tested
AID: 83367

323. Inhibitory concentration against TL3-resistant HIV(F53L) mutant protease
Source: ChEMBL
Protein Target: Pol polyprotein
Substance BioActivity: 3 Active, 3 Activity <= 1 µM, 3 Tested
AID: 83243

324. Inhibitory activity against HIV-1 Protease was determined
Source: ChEMBL
Protein Target: Pol polyprotein
Substance BioActivity: 1 Active, 1 Activity <= 1 nM, 1 Activity <= 1 µM, 1 Tested
AID: 82298

325. Inhibition of HIV RNA synthesis in T-cell line
Source: ChEMBL
Protein Target: Pol polyprotein
Substance BioActivity: 24 Active, 24 Activity <= 1 µM, 24 Tested
AID: 210277

326. Inhibitory concentration against TL3-resistant HIV(V82A) mutant
Source: ChEMBL
Protein Target: Pol polyprotein
Substance BioActivity: 4 Active, 4 Activity <= 1 µM, 4 Tested
AID: 83381

327. The compound was tested for HIV-1 protease inhibitory activity against plasmid pET9c-PR expressing HIV-1 protease.
Source: ChEMBL
Protein Target: Pol polyprotein
Substance BioActivity: 9 Active, 9 Tested
AID: 162509

328. The compound was tested for HIV-1 protease inhibitory activity against plasmid pET9c-PR expressing HIV-1 protease. activity is expressed as Kid value.
Source: ChEMBL
Protein Target: Pol polyprotein
Substance BioActivity: 4 Active, 2 Activity <= 1 µM, 4 Tested
AID: 160628

329. Inhibitory activity against HIV1 protease
Source: ChEMBL
Protein Target: Pol polyprotein
Substance BioActivity: 5 Active, 5 Activity <= 1 µM, 5 Tested
AID: 257268

330. Inhibitory concentration against HIV aspartyl protease
Source: ChEMBL
Protein Target: Pol polyprotein
Substance BioActivity: 1 Active, 4 Tested
AID: 241299

331. Effective concentration required to inhibit human immunodeficiency virus 1 protease in MT-4 cells
Source: ChEMBL
Protein Target: Pol polyprotein
Substance BioActivity: 2 Active, 2 Tested
AID: 240112

332. Binding affinity towards human immunodeficiency virus type 1 protease determined using continuum electrostatics solvation
Source: ChEMBL
Protein Target: Pol polyprotein
Substance BioActivity: 24 Active, 9 Activity <= 1 nM, 22 Activity <= 1 µM, 24 Tested
AID: 239453

333. Inhibition of HIV-1 protease by fluorometric assay
Source: ChEMBL
Protein Target: Pol polyprotein
Substance BioActivity: 25 Active, 19 Activity <= 1 µM, 25 Tested
AID: 160778

334. Inhibition of recombinant HIV-1 protease measured by fluorometric assay
Source: ChEMBL
Protein Target: Pol polyprotein
Substance BioActivity: 26 Active, 20 Activity <= 1 µM, 26 Tested
AID: 160459

335. Binding affinity against HIV-protease inhibitor.
Source: ChEMBL
Protein Target: Pol polyprotein
Substance BioActivity: 1 Active, 1 Activity <= 1 µM, 1 Tested
AID: 161874

336. Binding affinity against HIV-protease
Source: ChEMBL
Protein Target: Pol polyprotein
Substance BioActivity: 1 Active, 1 Activity <= 1 nM, 1 Activity <= 1 µM, 1 Tested
AID: 161873

337. Inhibition constant of HIV protease inhibitors
Source: ChEMBL
Protein Target: Pol polyprotein
Substance BioActivity: 83 Active, 37 Activity <= 1 nM, 78 Activity <= 1 µM, 83 Tested
AID: 160454

338. Binding affinity against HIV-1 protease.
Source: ChEMBL
Protein Target: Pol polyprotein
Substance BioActivity: 1 Active, 1 Activity <= 1 nM, 1 Activity <= 1 µM, 1 Tested
AID: 160272

339. Compound was tested for inhibition of HIV protease in AZT Resistant HIV-1 clinical isolates in primary PBMC
Source: ChEMBL
Protein Target: Pol polyprotein
Substance BioActivity: 1 Active, 1 Activity <= 1 µM, 1 Tested
AID: 162532

340. Tested for inhibition of HIV protease
Source: ChEMBL
Protein Target: Pol polyprotein
Substance BioActivity: 10 Active, 6 Activity <= 1 µM, 11 Tested
AID: 162531

341. Inhibition concentration against HIV-1 protease
Source: ChEMBL
Protein Target: Pol polyprotein
Substance BioActivity: 8 Active, 5 Activity <= 1 µM, 8 Tested
AID: 162189

342. Concentration needed to inhibit HIV- protease activity by 50%.
Source: ChEMBL
Protein Target: Pol polyprotein
Substance BioActivity: 3 Active, 3 Activity <= 1 nM, 3 Activity <= 1 µM, 3 Tested
AID: 162057

343. In vitro inhibition activity against HIV-1 protease.
Source: ChEMBL
Protein Target: Pol polyprotein
Substance BioActivity: 24 Active, 24 Activity <= 1 µM, 24 Tested
AID: 162054

344. Compound was tested for inhibition of HIV protease triple mutant (Q7K/L33I/L63I)
Source: ChEMBL
Protein Target: Pol polyprotein
Substance BioActivity: 1 Active, 1 Activity <= 1 µM, 1 Tested
AID: 162049

345. Tested for inhibition of HIV protease
Source: ChEMBL
Protein Target: Pol polyprotein
Substance BioActivity: 13 Active, 9 Activity <= 1 µM, 14 Tested
AID: 162048

346. Inhibition of HIV-1 protease
Source: ChEMBL
Protein Target: Pol polyprotein
Substance BioActivity: 12 Active, 5 Activity <= 1 nM, 12 Activity <= 1 µM, 12 Tested
AID: 162026

347. Ability to inhibit HIV-1 protease was determined using spectrofluorimetric assay.
Source: ChEMBL
Protein Target: Pol polyprotein
Substance BioActivity: 7 Active, 6 Activity <= 1 µM, 7 Tested
AID: 162025

348. Ability to inhibit HIV-1 protease was determined using spectrofluorimetric assay
Source: ChEMBL
Protein Target: Pol polyprotein
Substance BioActivity: 8 Active, 6 Activity <= 1 µM, 8 Tested
AID: 162024

349. In vivo for antiviral activity (ED90) against HIV-1 protease.
Source: ChEMBL
Protein Target: Pol polyprotein
Substance BioActivity: 30 Active, 29 Activity <= 1 µM, 30 Tested
AID: 161897

350. In vivo antiviral activity (IC50) against HIV-1 protease.
Source: ChEMBL
Protein Target: Pol polyprotein
Substance BioActivity: 30 Active, 30 Activity <= 1 µM, 30 Tested
AID: 161892

351. Cellular antiviral activity against HIV-1 Protease
Source: ChEMBL
Protein Target: Pol polyprotein
Substance BioActivity: 7 Active, 5 Activity <= 1 µM, 7 Tested
AID: 161883

352. Compound was tested for inhibition of HIV protease
Source: ChEMBL
Protein Target: Pol polyprotein
Substance BioActivity: 1 Active, 1 Activity <= 1 µM, 1 Tested
AID: 161508

353. Inhibitory activity against HIV protease
Source: ChEMBL
Protein Target: Pol polyprotein
Substance BioActivity: 53 Active, 53 Activity <= 1 nM, 53 Activity <= 1 µM, 53 Tested
AID: 160474

354. Inhibitory activity against HIV-1 protease
Source: ChEMBL
Protein Target: Pol polyprotein
Substance BioActivity: 5 Active, 1 Activity <= 1 nM, 5 Activity <= 1 µM, 5 Tested
AID: 160467

355. Compound was tested for inhibition of HIV-1 protease was assayed in infected MT-4 cells
Source: ChEMBL
Protein Target: Pol polyprotein
Substance BioActivity: 4 Active, 4 Activity <= 1 µM, 4 Tested
AID: 160439

356. Compound was tested for inhibition of HIV protease triple mutant (Q7K/L33I/L63I)
Source: ChEMBL
Protein Target: Pol polyprotein
Substance BioActivity: 2 Active, 2 Activity <= 1 nM, 2 Activity <= 1 µM, 2 Tested
AID: 160438

357. Tested for inhibition of HIV protease
Source: ChEMBL
Protein Target: Pol polyprotein
Substance BioActivity: 15 Active, 8 Activity <= 1 nM, 15 Activity <= 1 µM, 15 Tested
AID: 160437

358. Binding affinity for HIV-1 protease was determined.
Source: ChEMBL
Protein Target: Pol polyprotein
Substance BioActivity: 5 Active, 5 Activity <= 1 µM, 5 Tested
AID: 160284

359. Binding affinity for HIV-1 protease was determined in vitro.
Source: ChEMBL
Protein Target: Pol polyprotein
Substance BioActivity: 1 Active, 1 Activity <= 1 µM, 1 Tested
AID: 160283

360. Binding affinity for HIV-1 protease was determined in vitro
Source: ChEMBL
Protein Target: Pol polyprotein
Substance BioActivity: 3 Active, 1 Activity <= 1 nM, 3 Activity <= 1 µM, 3 Tested
AID: 160282

361. Binding affinity for HIV-1 protease was determined
Source: ChEMBL
Protein Target: Pol polyprotein
Substance BioActivity: 5 Active, 1 Activity <= 1 nM, 4 Activity <= 1 µM, 5 Tested
AID: 160281

362. Binding affinity against HIV-1 protease
Source: ChEMBL
Protein Target: Pol polyprotein
Substance BioActivity: 38 Active, 36 Activity <= 1 µM, 38 Tested
AID: 160276

363. Tested for inhibitory activity against HIV protease enzyme
Source: ChEMBL
Protein Target: Pol polyprotein
Substance BioActivity: 3 Active, 1 Activity <= 1 nM, 3 Activity <= 1 µM, 3 Tested
AID: 162377

364. Tested against S2-binding site of HIV-1 protease
Source: ChEMBL
Protein Target: Pol polyprotein
Substance BioActivity: 17 Active, 1 Activity <= 1 nM, 16 Activity <= 1 µM, 17 Tested
AID: 162376

365. In vitro inhibitory concentration against HIV-1 protease
Source: ChEMBL
Protein Target: Pol polyprotein
Substance BioActivity: 3 Active, 1 Activity <= 1 nM, 3 Activity <= 1 µM, 3 Tested
AID: 162185

366. Tested for the relative potency against HIV-1 protease in the cellular antiviral assay
Source: ChEMBL
Protein Target: Pol polyprotein
Substance BioActivity: 3 Active, 1 Activity <= 1 µM, 3 Tested
AID: 161886

367. Tested for antiviral potency against HIV protease enzyme
Source: ChEMBL
Protein Target: Pol polyprotein
Substance BioActivity: 3 Active, 3 Activity <= 1 µM, 3 Tested
AID: 161882

368. Tested for the binding affinity against HIV-1 Protease
Source: ChEMBL
Protein Target: Pol polyprotein
Substance BioActivity: 1 Active, 1 Activity <= 1 µM, 1 Tested
AID: 160612

369. Tested for the HIV Protease inhibitory activity of the compound
Source: ChEMBL
Protein Target: Pol polyprotein
Substance BioActivity: 2 Active, 2 Activity <= 1 µM, 2 Tested
AID: 160610

370. Inhibitory constant against HIV-1 protease
Source: ChEMBL
Protein Target: Pol polyprotein
Substance BioActivity: 45 Active, 43 Activity <= 1 µM, 46 Tested
AID: 160482

371. In vitro ability to inhibit HIV-protease.
Source: ChEMBL
Protein Target: Pol polyprotein
Substance BioActivity: 2 Active, 2 Activity <= 1 µM, 2 Tested
AID: 160309

372. Inhibition of HIV-1 protease
Source: ChEMBL
Protein Target: Pol polyprotein
Substance BioActivity: 13 Active, 6 Activity <= 1 nM, 13 Activity <= 1 µM, 14 Tested
AID: 163476

373. Inhibitory concentration was evaluated to inhibit the 95% of HIV-1 protease
Source: ChEMBL
Protein Target: Pol polyprotein
Substance BioActivity: 6 Active, 6 Activity <= 1 µM, 6 Tested
AID: 163473

374. The compound was tested for its affinity against HIV-1 protease in vitro
Source: ChEMBL
Protein Target: Pol polyprotein
Substance BioActivity: 1 Active, 1 Tested
AID: 162514

375. The compound was tested for its affinity against HIV-1 protease
Source: ChEMBL
Protein Target: Pol polyprotein
Substance BioActivity: 12 Active, 5 Activity <= 1 nM, 12 Activity <= 1 µM, 13 Tested
AID: 162513

376. Inhibitory activity of the Compound was tested against HIV protease enzyme.(value reported by Roche group)
Source: ChEMBL
Protein Target: Pol polyprotein
Substance BioActivity: 6 Active, 5 Activity <= 1 µM, 6 Tested
AID: 162348

377. Inhibitory activity of the Compound was tested against HIV protease enzyme
Source: ChEMBL
Protein Target: Pol polyprotein
Substance BioActivity: 1 Active, 1 Activity <= 1 µM, 1 Tested
AID: 162222

378. Inhibitory activity of the Compound was tested against HIV protease enzyme.(value reported by Roche group)
Source: ChEMBL
Protein Target: Pol polyprotein
Substance BioActivity: 1 Active, 2 Activity <= 1 µM, 2 Tested
AID: 162221

379. Inhibitory activity of the Compound was tested against HIV protease enzyme.
Source: ChEMBL
Protein Target: Pol polyprotein
Substance BioActivity: 10 Active, 1 Activity <= 1 nM, 9 Activity <= 1 µM, 10 Tested
AID: 162220

380. Inhibitory activity of the Compound was tested against HIV protease enzyme (by Dixon analysis)
Source: ChEMBL
Protein Target: Pol polyprotein
Substance BioActivity: 1 Active, 1 Activity <= 1 µM, 1 Tested
AID: 162219

381. Inhibitory activity of the Compound was tested against HIV protease enzyme
Source: ChEMBL
Protein Target: Pol polyprotein
Substance BioActivity: 1 Active, 1 Activity <= 1 µM, 1 Tested
AID: 162218

382. Inhibition of HIV-1 Protease.
Source: ChEMBL
Protein Target: Pol polyprotein
Substance BioActivity: 19 Active, 15 Activity <= 1 µM, 20 Tested
AID: 162056

383. Compounds were tested for their concentration to inhibit the HIV-1 Protease
Source: ChEMBL
Protein Target: Pol polyprotein
Substance BioActivity: 1 Active, 1 Tested
AID: 162055

384. Inhibition of HIV-1 protease in 10% fetal calf serum(FCS)
Source: ChEMBL
Protein Target: Pol polyprotein
Substance BioActivity: 4 Active, 1 Activity <= 1 µM, 12 Tested
AID: 162045

385. Inhibition of HIV-1 protease in 5%DMSO
Source: ChEMBL
Protein Target: Pol polyprotein
Substance BioActivity: 11 Active, 1 Activity <= 1 nM, 5 Activity <= 1 µM, 13 Tested
AID: 162042

386. Inhibitory concentration against HIV-1 protease in the absence of DMSO
Source: ChEMBL
Protein Target: Pol polyprotein
Substance BioActivity: 3 Active, 3 Activity <= 1 µM, 3 Tested
AID: 161866

387. Concentration required to inhibit HIV-1 protease activity calculated from plots of % inhibition vs inhibitor concentration
Source: ChEMBL
Protein Target: Pol polyprotein
Substance BioActivity: 2 Active, 1 Activity <= 1 µM, 5 Tested
AID: 161865

388. In vitro binding affinity against HIV protease was measured
Source: ChEMBL
Protein Target: Pol polyprotein
Substance BioActivity: 2 Active, 2 Activity <= 1 nM, 2 Activity <= 1 µM, 2 Tested
AID: 161383

389. In vitro concentration required to inhibit 50% activity of HIV protease was measured (exp 2)
Source: ChEMBL
Protein Target: Pol polyprotein
Substance BioActivity: 2 Active, 2 Activity <= 1 µM, 2 Tested
AID: 161382

390. In vitro concentration required to inhibit 50% activity of HIV protease was measured
Source: ChEMBL
Protein Target: Pol polyprotein
Substance BioActivity: 10 Active, 10 Activity <= 1 µM, 10 Tested
AID: 161381

391. Inhibition of HIV-1 protease
Source: ChEMBL
Protein Target: Pol polyprotein
Substance BioActivity: 14 Active, 7 Activity <= 1 nM, 14 Activity <= 1 µM, 14 Tested
AID: 161380

392. Inhibition of HIV protease
Source: ChEMBL
Protein Target: Pol polyprotein
Substance BioActivity: 12 Active, 2 Activity <= 1 nM, 11 Activity <= 1 µM, 12 Tested
AID: 161379

393. The compound was tested for its affinity against HIV-1 protease; range 400-1400 nM
Source: ChEMBL
Protein Target: Pol polyprotein
Substance BioActivity: 1 Active, 1 Tested
AID: 160617

394. Binding affinity for HIV-1 protease
Source: ChEMBL
Protein Target: Pol polyprotein
Substance BioActivity: 13 Active, 4 Activity <= 1 nM, 10 Activity <= 1 µM, 13 Tested
AID: 160616

395. Tested for inhibitory activity against HIV-1 protease
Source: ChEMBL
Protein Target: Pol polyprotein
Substance BioActivity: 10 Active, 10 Activity <= 1 µM, 10 Tested
AID: 160608

396. Binding affinity against HIV protease enzyme.(by Dixon analysis)
Source: ChEMBL
Protein Target: Pol polyprotein
Substance BioActivity: 1 Active, 1 Activity <= 1 nM, 1 Activity <= 1 µM, 1 Tested
AID: 160290

397. Binding affinity against HIV Protease enzyme.(by Dixon analysis)
Source: ChEMBL
Protein Target: Pol polyprotein
Substance BioActivity: 2 Active, 1 Activity <= 1 nM, 2 Activity <= 1 µM, 2 Tested
AID: 160289

398. Inhibitory concentration against HIV-1 protease in the absence of DMSO
Source: ChEMBL
Protein Target: Pol polyprotein
Substance BioActivity: 1 Active, 1 Activity <= 1 µM, 1 Tested
AID: 82622

399. Inhibitory activity against recombinant HIV-1 protease.
Source: ChEMBL
Protein Target: Pol polyprotein
Substance BioActivity: 2 Active, 2 Activity <= 1 nM, 2 Activity <= 1 µM, 2 Tested
AID: 162210

400. Inhibitory activity against recombinant HIV-1 Protease
Source: ChEMBL
Protein Target: Pol polyprotein
Substance BioActivity: 8 Active, 1 Activity <= 1 nM, 9 Activity <= 1 µM, 10 Tested
AID: 162209

401. Inhibition of HIV protease at pH 6.4, 37 degree C
Source: ChEMBL
Protein Target: Pol polyprotein
Substance BioActivity: 13 Active, 2 Activity <= 1 nM, 8 Activity <= 1 µM, 13 Tested
AID: 160464

402. Inhibitory activity against HIV Protease was measured at pH 6.4 and 37 degrees C
Source: ChEMBL
Protein Target: Pol polyprotein
Substance BioActivity: 3 Active, 2 Activity <= 1 µM, 4 Tested
AID: 160460

403. Inhibitory activity against HIV-1 protease (Q-60C strain)
Source: ChEMBL
Protein Target: Pol polyprotein
Substance BioActivity: 2 Active, 1 Activity <= 1 nM, 2 Activity <= 1 µM, 2 Tested
AID: 162353

404. Inhibitory activity of compound against HIV-1 protease in HIV-1 (Q-60C) strain
Source: ChEMBL
Protein Target: Pol polyprotein
Substance BioActivity: 7 Active, 3 Activity <= 1 nM, 7 Activity <= 1 µM, 7 Tested
AID: 162213

405. Inhibitory activity of compound against HIV-1 protease in HIV-1 (K-60C) strain
Source: ChEMBL
Protein Target: Pol polyprotein
Substance BioActivity: 8 Active, 3 Activity <= 1 nM, 8 Activity <= 1 µM, 8 Tested
AID: 162211

406. Inhibitory concentration against Protease
Source: ChEMBL
Protein Target: Pol polyprotein
Substance BioActivity: 9 Active, 1 Activity <= 1 µM, 23 Tested
AID: 161737

407. Inhibitory activity against HIV-1 protease
Source: ChEMBL
Protein Target: Pol polyprotein
Substance BioActivity: 35 Active, 2 Activity <= 1 nM, 43 Activity <= 1 µM, 43 Tested
AID: 160449

408. Binding affinity against HIV-Protease was determined
Source: ChEMBL
Protein Target: Pol polyprotein
Substance BioActivity: 10 Active, 10 Activity <= 1 nM, 10 Activity <= 1 µM, 10 Tested
AID: 160279

409. Tested in vitro for the ability to inhibit cleavage of a substrate by the wild type HIV-1 protease
Source: ChEMBL
Protein Target: Pol polyprotein
Substance BioActivity: 4 Active, 4 Activity <= 1 nM, 4 Activity <= 1 µM, 4 Tested
AID: 82781

410. Compound was tested for inhibitory activity against HIV-1 protease
Source: ChEMBL
Protein Target: Pol polyprotein
Substance BioActivity: 8 Active, 3 Activity <= 1 µM, 8 Tested
AID: 82627

411. In vitro binding affinity to HIV protease was determined at pH 4.7
Source: ChEMBL
Protein Target: Pol polyprotein
Substance BioActivity: 2 Active, 2 Activity <= 1 µM, 2 Tested
AID: 162179

412. In vitro binding affinity against HIV protease at pH 6.2.
Source: ChEMBL
Protein Target: Pol polyprotein
Substance BioActivity: 26 Active, 26 Activity <= 1 µM, 26 Tested
AID: 162178

413. In vitro binding affinity to HIV protease was determined
Source: ChEMBL
Protein Target: Pol polyprotein
Substance BioActivity: 1 Active, 1 Tested
AID: 161891

414. Inhibitory activity against HIV protease; Active
Source: ChEMBL
Protein Target: Pol polyprotein
Substance BioActivity: 8 Active, 8 Tested
AID: 161880

415. In vitro binding affinity against HIV protease at pH 6.2 was determined
Source: ChEMBL
Protein Target: Pol polyprotein
Substance BioActivity: 2 Active, 2 Activity <= 1 nM, 2 Activity <= 1 µM, 2 Tested
AID: 160448

416. Compound was tested for the inhibitory activity against HIV-protease
Source: ChEMBL
Protein Target: Pol polyprotein
Substance BioActivity: 5 Active, 3 Activity <= 1 µM, 5 Tested
AID: 160446

417. Inhibition of HIV-protease
Source: ChEMBL
Protein Target: Pol polyprotein
Substance BioActivity: 13 Active, 11 Activity <= 1 µM, 13 Tested
AID: 160445

418. Inhibition of HIV-1 protease.
Source: ChEMBL
Protein Target: Pol polyprotein
Substance BioActivity: 20 Active, 4 Activity <= 1 nM, 20 Activity <= 1 µM, 20 Tested
AID: 160299

419. Binding affinity towards HIV protease was determined
Source: ChEMBL
Protein Target: Pol polyprotein
Substance BioActivity: 2 Active, 1 Activity <= 1 nM, 2 Activity <= 1 µM, 2 Tested
AID: 160286

420. Compound was tested for the inhibitory activity against HIV-protease
Source: ChEMBL
Protein Target: Pol polyprotein
Substance BioActivity: 1 Active, 1 Tested
AID: 83432

421. Inhibition constant of ritonavir towards HIV protease was determined
Source: ChEMBL
Protein Target: Pol polyprotein
Substance BioActivity: 1 Active, 1 Activity <= 1 nM, 1 Activity <= 1 µM, 1 Tested
AID: 82914

422. Inhibitory activity against HIV-1 protease using scintillation proximity assay (SPA assay)
Source: ChEMBL
Protein Target: Pol polyprotein
Substance BioActivity: 16 Active, 16 Activity <= 1 µM, 16 Tested
AID: 82767

423. Binding affinity for HIV -1 Protease
Source: ChEMBL
Protein Target: Pol polyprotein
Substance BioActivity: 11 Active, 11 Activity <= 1 nM, 11 Activity <= 1 µM, 11 Tested
AID: 82295

424. Inhibitory activity against HIV -1 Protease in whole cell assay
Source: ChEMBL
Protein Target: Pol polyprotein
Substance BioActivity: 11 Active, 11 Activity <= 1 µM, 11 Tested
AID: 82294

425. Compound was evaluated for the inhibition of HIV protease
Source: ChEMBL
Protein Target: Pol polyprotein
Substance BioActivity: 5 Active, 2 Activity <= 1 nM, 5 Activity <= 1 µM, 8 Tested
AID: 163475

426. In vitro inhibitory activity against purified HIV-1 protease at a pH of 4.7 and a final enzyme concentration of 0.45-1.1 nM
Source: ChEMBL
Protein Target: Pol polyprotein
Substance BioActivity: 25 Active, 21 Activity <= 1 µM, 25 Tested
AID: 163474

427. Compound was evaluated for its antiviral activity against HIV-Protease in cell based assay.
Source: ChEMBL
Protein Target: Pol polyprotein
Substance BioActivity: 2 Active, 2 Activity <= 1 µM, 2 Tested
AID: 162530

428. In vitro inhibition of HIV-1 protease at pH 6 using 164 uM peptide substrate
Source: ChEMBL
Protein Target: Pol polyprotein
Substance BioActivity: 14 Active, 13 Activity <= 1 µM, 18 Tested
AID: 162515

429. Inhibitory activity against HIV-1 protease
Source: ChEMBL
Protein Target: Pol polyprotein
Substance BioActivity: 10 Active, 10 Activity <= 1 µM, 12 Tested
AID: 162379

430. Tested for inhibitory activity against the recombinant HIV-1 protease
Source: ChEMBL
Protein Target: Pol polyprotein
Substance BioActivity: 2 Active, 2 Activity <= 1 µM, 5 Tested
AID: 162378

431. Inhibition of HIV protease cleavage of V-S-Q-N-(b-naphthylalanine)-P-I-V
Source: ChEMBL
Protein Target: Pol polyprotein
Substance BioActivity: 12 Active, 10 Activity <= 1 µM, 14 Tested
AID: 162375

432. Inhibitory activity was evaluated against recombinant HIV-1 protease using spectrofluorimetric assay
Source: ChEMBL
Protein Target: Pol polyprotein
Substance BioActivity: 7 Active, 7 Activity <= 1 µM, 7 Tested
AID: 162367

433. Inhibitory activity against HIV-1 protease
Source: ChEMBL
Protein Target: Pol polyprotein
Substance BioActivity: 10 Active, 2 Activity <= 1 nM, 12 Activity <= 1 µM, 12 Tested
AID: 162362

434. Inhibitory activity against HIV-1 protease in spectrofluorimetric assay
Source: ChEMBL
Protein Target: Pol polyprotein
Substance BioActivity: 11 Active, 11 Activity <= 1 µM, 11 Tested
AID: 162358

435. Inhibitory activity against HIV-1 Protease was determined
Source: ChEMBL
Protein Target: Pol polyprotein
Substance BioActivity: 6 Active, 1 Activity <= 1 nM, 6 Activity <= 1 µM, 6 Tested
AID: 162203

436. In vitro inhibitory activity against HIV-1 protease(PR).
Source: ChEMBL
Protein Target: Pol polyprotein
Substance BioActivity: 35 Active, 17 Activity <= 1 µM, 37 Tested
AID: 162183

437. Concentration required for in vitro inhibitory activity against HIV-1 protease
Source: ChEMBL
Protein Target: Pol polyprotein
Substance BioActivity: 4 Active, 2 Activity <= 1 nM, 5 Activity <= 1 µM, 5 Tested
AID: 162063

438. Concentration required for in vitro inhibition of HIV-1 protease
Source: ChEMBL
Protein Target: Pol polyprotein
Substance BioActivity: 4 Active, 4 Activity <= 1 µM, 4 Tested
AID: 162062

439. In vitro inhibition of HIV-1 protease.
Source: ChEMBL
Protein Target: Pol polyprotein
Substance BioActivity: 15 Active, 9 Activity <= 1 µM, 16 Tested
AID: 162060

440. Concentration required for inhibitory activity against HIV-1 Protease
Source: ChEMBL
Protein Target: Pol polyprotein
Substance BioActivity: 14 Active, 14 Activity <= 1 µM, 16 Tested
AID: 162059

441. Inhibition of HIV-1 protease.
Source: ChEMBL
Protein Target: Pol polyprotein
Substance BioActivity: 15 Active, 13 Activity <= 1 µM, 15 Tested
AID: 162052

442. Compound was evaluated for the inhibition of HIV protease
Source: ChEMBL
Protein Target: Pol polyprotein
Substance BioActivity: 5 Active, 4 Activity <= 1 µM, 6 Tested
AID: 162035

443. Compound was evaluated for its inhibitory activity in recombinant HIV-l protease
Source: ChEMBL
Protein Target: Pol polyprotein
Substance BioActivity: 3 Active, 2 Activity <= 1 µM, 3 Tested
AID: 162034

444. Compound was evaluated for its inhibitory activity against recombinant HIV-1 protease using [125I]-SPA (scintillation proximity assay)
Source: ChEMBL
Protein Target: Pol polyprotein
Substance BioActivity: 1 Active, 1 Tested
AID: 162033

445. Apparent inhibitory constant against HIV-1 protease was determined
Source: ChEMBL
Protein Target: Pol polyprotein
Substance BioActivity: 10 Active, 1 Activity <= 1 µM, 16 Tested
AID: 160625

446. Inhibitory activity against HIV-1 protease
Source: ChEMBL
Protein Target: Pol polyprotein
Substance BioActivity: 23 Active, 2 Activity <= 1 nM, 15 Activity <= 1 µM, 23 Tested
AID: 160624

447. Tested for inhibitory activity against the recombinant HIV-1 protease
Source: ChEMBL
Protein Target: Pol polyprotein
Substance BioActivity: 4 Active, 3 Activity <= 1 nM, 4 Activity <= 1 µM, 9 Tested
AID: 160609

448. Tested for inhibitory activity against HIV protease
Source: ChEMBL
Protein Target: Pol polyprotein
Substance BioActivity: 1 Active, 1 Activity <= 1 nM, 1 Activity <= 1 µM, 1 Tested
AID: 160607

449. Inhibitory activity was evaluated against HIV protease
Source: ChEMBL
Protein Target: Pol polyprotein
Substance BioActivity: 23 Active, 11 Activity <= 1 nM, 23 Activity <= 1 µM, 23 Tested
AID: 160480

450. Inhibitory activity HIV-1 protease enzyme
Source: ChEMBL
Protein Target: Pol polyprotein
Substance BioActivity: 17 Active, 17 Activity <= 1 µM, 17 Tested
AID: 160478

451. Inhibitory activity against HIV protease was determined
Source: ChEMBL
Protein Target: Pol polyprotein
Substance BioActivity: 3 Active, 1 Activity <= 1 nM, 2 Activity <= 1 µM, 5 Tested
AID: 160463

452. Inhibition constant against HIV protease was determined
Source: ChEMBL
Protein Target: Pol polyprotein
Substance BioActivity: 2 Active, 2 Activity <= 1 µM, 2 Tested
AID: 160453

453. Evaluated for inhibitory activity against HIV-1 protease
Source: ChEMBL
Protein Target: Pol polyprotein
Substance BioActivity: 16 Active, 1 Activity <= 1 nM, 18 Activity <= 1 µM, 18 Tested
AID: 160307

454. Compound was evaluated for the inhibition of recombinant HIV-1 protease at 37 degrees C and pH of 6.
Source: ChEMBL
Protein Target: Pol polyprotein
Substance BioActivity: 3 Active, 7 Tested
AID: 160306

455. Inhibition of HIV-1 protease.
Source: ChEMBL
Protein Target: Pol polyprotein
Substance BioActivity: 34 Active, 1 Activity <= 1 nM, 25 Activity <= 1 µM, 35 Tested
AID: 160305

456. Compound was evaluated for its binding affinity against HIV-1 protease using [125I]-SPA (scintillation proximity assay)
Source: ChEMBL
Protein Target: Pol polyprotein
Substance BioActivity: 1 Active, 1 Activity <= 1 µM, 1 Tested
AID: 160302

457. Inhibitory activity against HIV protease enzyme.
Source: ChEMBL
Protein Target: Pol polyprotein
Substance BioActivity: 11 Active, 3 Activity <= 1 µM, 11 Tested
AID: 160298

458. Compound was evaluated for binding affinity towards HIV-Protease enzyme.
Source: ChEMBL
Protein Target: Pol polyprotein
Substance BioActivity: 2 Active, 2 Activity <= 1 nM, 2 Activity <= 1 µM, 2 Tested
AID: 160295

459. The compound was evaluated for irreversible inhibition of HIV-1 protease
Source: ChEMBL
Protein Target: Pol polyprotein
Substance BioActivity: 2 Active, 1 Activity <= 1 µM, 4 Tested
AID: 82934

460. Concentration of compound for half maximal inactivation rate on protease of Human immunodeficiency virus-1 (HIV-I) was determined
Source: ChEMBL
Protein Target: Pol polyprotein
Substance BioActivity: 1 Active, 1 Tested
AID: 82908

461. Tested for inhibitory activity against the recombinant HIV-1 protease
Source: ChEMBL
Protein Target: Pol polyprotein
Substance BioActivity: 3 Active, 1 Activity <= 1 µM, 3 Tested
AID: 82802

462. Tested for inhibitory activity against HIV protease
Source: ChEMBL
Protein Target: Pol polyprotein
Substance BioActivity: 3 Active, 2 Activity <= 1 nM, 3 Activity <= 1 µM, 3 Tested
AID: 82801

463. Inhibitory activity against purified HIV protease
Source: ChEMBL
Protein Target: Pol polyprotein
Substance BioActivity: 1 Active, 1 Activity <= 1 nM, 1 Activity <= 1 µM, 1 Tested
AID: 82795

464. Compound was tested for its inhibitory activity against HIV-1 protease
Source: ChEMBL
Protein Target: Pol polyprotein
Substance BioActivity: 9 Active, 2 Activity <= 1 nM, 9 Activity <= 1 µM, 9 Tested
AID: 82794

465. Compound was tested for inactivation of purified HIV-1 protease in vitro
Source: ChEMBL
Protein Target: Pol polyprotein
Substance BioActivity: 4 Active, 1 Activity <= 1 nM, 4 Activity <= 1 µM, 4 Tested
AID: 82793

466. Compound was evaluated for its binding affinity against HIV-1 protease
Source: ChEMBL
Protein Target: Pol polyprotein
Substance BioActivity: 2 Active, 4 Tested
AID: 82792

467. Binding affinity for HIV-1 protease
Source: ChEMBL
Protein Target: Pol polyprotein
Substance BioActivity: 13 Active, 12 Activity <= 1 µM, 13 Tested
AID: 82789

468. Tested in vitro for the ability to inhibit HIV-1 protease at pH 7.4
Source: ChEMBL
Protein Target: Pol polyprotein
Substance BioActivity: 3 Active, 3 Activity <= 1 µM, 3 Tested
AID: 82780

469. Tested in vitro for the ability to inhibit HIV-1 protease
Source: ChEMBL
Protein Target: Pol polyprotein
Substance BioActivity: 16 Active, 16 Activity <= 1 µM, 16 Tested
AID: 82779

470. Tested for inhibitory activity against the recombinant HIV-1 protease
Source: ChEMBL
Protein Target: Pol polyprotein
Substance BioActivity: 1 Active, 1 Activity <= 1 µM, 1 Tested
AID: 82777

471. Inhibitory concentration required against HIV-1 protease
Source: ChEMBL
Protein Target: Pol polyprotein
Substance BioActivity: 7 Active, 3 Activity <= 1 nM, 7 Activity <= 1 µM, 7 Tested
AID: 82775

472. Inhibitory concentration against HIV-1 protease
Source: ChEMBL
Protein Target: Pol polyprotein
Substance BioActivity: 2 Active, 1 Activity <= 1 nM, 2 Activity <= 1 µM, 2 Tested
AID: 82774

473. In vitro inhibition of HIV-1 protease.
Source: ChEMBL
Protein Target: Pol polyprotein
Substance BioActivity: 18 Active, 7 Activity <= 1 nM, 18 Activity <= 1 µM, 18 Tested
AID: 82765

474. Inhibitory activity if the compound was determined against HIV protease
Source: ChEMBL
Protein Target: Pol polyprotein
Substance BioActivity: 6 Active, 6 Activity <= 1 µM, 6 Tested
AID: 82640

475. Inhibitory activity against purified HIV protease
Source: ChEMBL
Protein Target: Pol polyprotein
Substance BioActivity: 29 Active, 29 Activity <= 1 µM, 29 Tested
AID: 82639

476. Inhibitory activity against HIV-1 protease
Source: ChEMBL
Protein Target: Pol polyprotein
Substance BioActivity: 25 Active, 11 Activity <= 1 nM, 25 Activity <= 1 µM, 25 Tested
AID: 82638

477. Inhibition of Human Immunodeficiency virus-1 protease
Source: ChEMBL
Protein Target: Pol polyprotein
Substance BioActivity: 13 Active, 11 Activity <= 1 nM, 13 Activity <= 1 µM, 13 Tested
AID: 82637

478. In vitro inhibitory activity against HIV-1 protease was evaluated
Source: ChEMBL
Protein Target: Pol polyprotein
Substance BioActivity: 23 Active, 22 Activity <= 1 µM, 23 Tested
AID: 82636

479. In vitro inhibitory activity against HIV-1 protease enzyme.
Source: ChEMBL
Protein Target: Pol polyprotein
Substance BioActivity: 9 Active, 1 Activity <= 1 nM, 9 Activity <= 1 µM, 9 Tested
AID: 82635

480. Concentration required for in vitro inhibition of HIV-1 protease
Source: ChEMBL
Protein Target: Pol polyprotein
Substance BioActivity: 3 Active, 3 Activity <= 1 µM, 3 Tested
AID: 82632

481. Compound was tested for inhibitory activity against recombinant HIV-1 protease using 125 I-SPA (scintillation proximity assay)
Source: ChEMBL
Protein Target: Pol polyprotein
Substance BioActivity: 6 Active, 5 Activity <= 1 µM, 7 Tested
AID: 82631

482. Compound was tested for inactivation of purified HIV-1 protease in vitro
Source: ChEMBL
Protein Target: Pol polyprotein
Substance BioActivity: 9 Active, 8 Activity <= 1 µM, 9 Tested
AID: 82626

483. Inhibitory activity against HIV-1 protease
Source: ChEMBL
Protein Target: Pol polyprotein
Substance BioActivity: 2 Active, 2 Activity <= 1 µM, 2 Tested
AID: 82621

484. Inhibitory activity against HIV-1 protease
Source: ChEMBL
Protein Target: Pol polyprotein
Substance BioActivity: 1 Active, 4 Tested
AID: 82616

485. The compound was evaluated for its inhibition constant against HIV-1 protease (HIV PR)
Source: ChEMBL
Protein Target: Pol polyprotein
Substance BioActivity: 2 Active, 1 Activity <= 1 µM, 2 Tested
AID: 82615

486. Compound was tested for the inhibition activity against HIV-1 protease
Source: ChEMBL
Protein Target: Pol polyprotein
Substance BioActivity: 9 Active, 3 Activity <= 1 nM, 9 Activity <= 1 µM, 10 Tested
AID: 82297

487. Binding affinity to HIV-protease
Source: ChEMBL
Protein Target: Pol polyprotein
Substance BioActivity: 1 Active, 24 Activity <= 1 µM, 24 Tested
AID: 82296

488. Inhibition of HIV-1 Protease
Source: ChEMBL
Protein Target: Pol polyprotein
Substance BioActivity: 14 Active, 12 Activity <= 1 µM, 14 Tested
AID: 82293

489. Inhibition of human immunodeficiency virus type 1 (HIV-1) protease
Source: ChEMBL
Protein Target: Pol polyprotein
Substance BioActivity: 9 Active, 3 Activity <= 1 µM, 13 Tested
AID: 82292

490. In vitro inhibition HIV-1 IIIB protease.
Source: ChEMBL
Protein Target: Pol polyprotein
Substance BioActivity: 17 Active, 3 Activity <= 1 nM, 17 Activity <= 1 µM, 18 Tested
AID: 82291

491. Inhibition of HIV-1 Protease
Source: ChEMBL
Protein Target: Pol polyprotein
Substance BioActivity: 13 Active, 11 Activity <= 1 nM, 13 Activity <= 1 µM, 13 Tested
AID: 82290

492. In vitro inhibitory activity of compound against HIV protease from BRU (IIIB) strain of HIV- 1 virus was determined
Source: ChEMBL
Protein Target: Pol polyprotein
Substance BioActivity: 1 Active, 1 Activity <= 1 µM, 1 Tested
AID: 82289

493. Inhibitory activity against HIV protease
Source: ChEMBL
Protein Target: Pol polyprotein
Substance BioActivity: 7 Active, 1 Activity <= 1 nM, 7 Activity <= 1 µM, 7 Tested
AID: 82288

494. Inhibitory concentration for antiviral inhibition against HIV-1 in MT-4 cell culture
Source: ChEMBL
Protein Target: Pol polyprotein
Substance BioActivity: 16 Active, 16 Activity <= 1 µM, 16 Tested
AID: 241508

495. Binding affinity against ritonavir-resistant strains.
Source: ChEMBL
Protein Target: Pol polyprotein
Substance BioActivity: 1 Active, 1 Activity <= 1 nM, 1 Activity <= 1 µM, 1 Tested
AID: 163477

496. Inhibition of HIV-1 proteinase was assayed in infected MT-4 cells
Source: ChEMBL
Protein Target: Pol polyprotein
Substance BioActivity: 14 Active, 14 Activity <= 1 µM, 14 Tested
AID: 160440

497. The 50% inhibitory concentration was measured as inhibition of RNA-dependent DNA polymerase activity
Source: ChEMBL
Protein Target: Pol polyprotein
Substance BioActivity: 6 Active, 2 Activity <= 1 µM, 6 Tested
AID: 198413

498. The 50% inhibitory concentration was measured as inhibition of DNA-dependent DNA polymerase activity
Source: ChEMBL
Protein Target: Pol polyprotein
Substance BioActivity: 5 Active, 6 Tested
AID: 198412

499. Antiviral potency of HIV-1 in MT-4 human T lymphoid cells with IIIb isolate
Source: ChEMBL
Protein Target: Pol polyprotein
Substance BioActivity: 12 Active, 11 Activity <= 1 µM, 13 Tested
AID: 105168

500. Inhibition of the spread of HIV-1 IIIb infection in MT-4 human T-lymphoid cells
Source: ChEMBL
Protein Target: Pol polyprotein
Substance BioActivity: 11 Active, 11 Activity <= 1 µM, 13 Tested
AID: 104947

501. Antiviral activity against the HTLV-III strain of HIV-1 in CEM cell lines
Source: ChEMBL
Protein Target: Pol polyprotein
Substance BioActivity: 3 Active, 2 Activity <= 1 µM, 12 Tested
AID: 46762

502. Effective dose against protease of human immunodeficiency virus type 1
Source: ChEMBL
Protein Target: Pol polyprotein
Substance BioActivity: 1 Active, 1 Activity <= 1 µM, 1 Tested
AID: 240429

503. Binding affinity against HIV-1 protease enzyme.
Source: ChEMBL
Protein Target: Pol polyprotein
Substance BioActivity: 1 Active, 1 Activity <= 1 nM, 1 Activity <= 1 µM, 1 Tested
AID: 160273

504. Compound was tested for inhibition of HIV protease triple mutant (Q7K/L33I/L63I)
Source: ChEMBL
Protein Target: Pol polyprotein
Substance BioActivity: 1 Active, 1 Activity <= 1 µM, 1 Tested
AID: 162533

505. Tested for the activity against HIV protease
Source: ChEMBL
Protein Target: Pol polyprotein
Substance BioActivity: 1 Active, 1 Tested
AID: 160636

506. Inhibitory activity of the Compound was tested against HIV protease enzyme.
Source: ChEMBL
Protein Target: Pol polyprotein
Substance BioActivity: 7 Active, 7 Activity <= 1 µM, 7 Tested
AID: 162223

507. Inhibitory activity of the Compound was tested against HIV protease enzyme.(value reported by Rich etal)
Source: ChEMBL
Protein Target: Pol polyprotein
Substance BioActivity: 1 Active, 1 Activity <= 1 µM, 1 Tested
AID: 82903

508. Tested for inhibitory activity against HIV-1 protease
Source: ChEMBL
Protein Target: Pol polyprotein
Substance BioActivity: 1 Active, 1 Activity <= 1 nM, 1 Activity <= 1 µM, 1 Tested
AID: 80894

509. Concentration required for inhibitory activity against HIV-1 protease
Source: ChEMBL
Protein Target: Pol polyprotein
Substance BioActivity: 1 Active, 1 Activity <= 1 µM, 1 Tested
AID: 163492

510. Inhibitory activity against P2 site in HIV protease.
Source: ChEMBL
Protein Target: Pol polyprotein
Substance BioActivity: 7 Active, 6 Activity <= 1 nM, 7 Activity <= 1 µM, 7 Tested
AID: 163478

511. Inhibitory activity was evaluated against HIV-1 protease
Source: ChEMBL
Protein Target: Pol polyprotein
Substance BioActivity: 3 Active, 3 Activity <= 1 µM, 4 Tested
AID: 162363

512. Inhibitory activity against purified HIV-1 protease (BH10) at a pH of 4.7 and a final enzyme concentration of 0.45-1.1 nM
Source: ChEMBL
Protein Target: Pol polyprotein
Substance BioActivity: 32 Active, 29 Activity <= 1 µM, 32 Tested
AID: 162207

513. In vitro inhibition of HIV-1 protease, activity expressed as CIC95 in whole cell assay.
Source: ChEMBL
Protein Target: Pol polyprotein
Substance BioActivity: 3 Active, 2 Activity <= 1 µM, 3 Tested
AID: 161884

514. Inhibitory constant against HIV-1 protease was determined
Source: ChEMBL
Protein Target: Pol polyprotein
Substance BioActivity: 1 Active, 5 Tested
AID: 160603

515. Inhibitory constant against HIV-1 protease
Source: ChEMBL
Protein Target: Pol polyprotein
Substance BioActivity: 1 Active, 3 Tested
AID: 160601

516. Inhibitory activity against HIV-1 protease
Source: ChEMBL
Protein Target: Pol polyprotein
Substance BioActivity: 28 Active, 10 Activity <= 1 nM, 26 Activity <= 1 µM, 28 Tested
AID: 82804

517. Tested for inhibition of HIV protease using fluorogenic substrate
Source: ChEMBL
Protein Target: Pol polyprotein
Substance BioActivity: 13 Active, 4 Activity <= 1 nM, 13 Activity <= 1 µM, 15 Tested
AID: 82798

518. Inhibitory activity was evaluated against HIV-1 protease
Source: ChEMBL
Protein Target: Pol polyprotein
Substance BioActivity: 3 Active, 4 Tested
AID: 82769

519. Compound was tested for inactivation of purified HIV-1 protease in vitro
Source: ChEMBL
Protein Target: Pol polyprotein
Substance BioActivity: 1 Active, 1 Activity <= 1 nM, 1 Activity <= 1 µM, 1 Tested
AID: 82745

520. Concentration required for in vitro inhibitory activity against HIV-1 protease
Source: ChEMBL
Protein Target: Pol polyprotein
Substance BioActivity: 5 Active, 9 Activity <= 1 µM, 9 Tested
AID: 82633

521. Compound was tested for inhibitory activity against Human immunodeficiency virus (HIV-1) protease
Source: ChEMBL
Protein Target: Pol polyprotein
Substance BioActivity: 7 Active, 1 Activity <= 1 nM, 7 Activity <= 1 µM, 7 Tested
AID: 82629

522. Inhibitory activity was determined against HIV-1 protease.
Source: ChEMBL
Protein Target: Pol polyprotein
Substance BioActivity: 18 Active, 2 Activity <= 1 nM, 17 Activity <= 1 µM, 18 Tested
AID: 82617

523. Antiviral activity as inhibition of HIV protease; Active
Source: ChEMBL
Protein Target: Pol polyprotein
Substance BioActivity: 2 Active, 2 Tested
AID: 161878

524. Inhibition of HIV-1 protease
Source: ChEMBL
Protein Target: Pol polyprotein
Substance BioActivity: 11 Active, 3 Activity <= 1 nM, 10 Activity <= 1 µM, 13 Tested
AID: 162040

525. Effective concentration of compound for inhibition of HIV 1 protease was determined
Source: ChEMBL
Protein Target: Pol polyprotein
Substance BioActivity: 6 Active, 6 Activity <= 1 µM, 6 Tested
AID: 161889

526. Compound was evaluated for the inhibitory activity against HIV-1 protease
Source: ChEMBL
Protein Target: Pol polyprotein
Substance BioActivity: 6 Active, 5 Activity <= 1 nM, 6 Activity <= 1 µM, 6 Tested
AID: 160308

527. The compound was tested for binding activity against HIV-1 protease
Source: ChEMBL
Protein Target: Pol polyprotein
Substance BioActivity: 1 Active, 1 Activity <= 1 nM, 1 Activity <= 1 µM, 1 Tested
AID: 163472

528. The compound was tested for binding activity against HIV-1 Protease
Source: ChEMBL
Protein Target: Pol polyprotein
Substance BioActivity: 2 Active, 2 Activity <= 1 nM, 2 Activity <= 1 µM, 2 Tested
AID: 163471

529. Binding activity against HIV-1 Protease
Source: ChEMBL
Protein Target: Pol polyprotein
Substance BioActivity: 3 Active, 3 Activity <= 1 nM, 3 Activity <= 1 µM, 3 Tested
AID: 163470

530. Binding activity against HIV-1 Protease
Source: ChEMBL
Protein Target: Pol polyprotein
Substance BioActivity: 6 Active, 1 Activity <= 1 nM, 11 Activity <= 1 µM, 11 Tested
AID: 163469

531. Binding activity against HIV-1 Protease
Source: ChEMBL
Protein Target: Pol polyprotein
Substance BioActivity: 6 Active, 1 Activity <= 1 nM, 11 Activity <= 1 µM, 11 Tested
AID: 163468

532. Inhibitory activity towards HIV-1 protease
Source: ChEMBL
Protein Target: Pol polyprotein
Substance BioActivity: 6 Active, 1 Activity <= 1 nM, 5 Activity <= 1 µM, 11 Tested
AID: 162361

533. Inhibitory activity against HIV-1 protease.
Source: ChEMBL
Protein Target: Pol polyprotein
Substance BioActivity: 23 Active, 1 Activity <= 1 nM, 19 Activity <= 1 µM, 35 Tested
AID: 161736

534. Inhibitory activity against HIV-1 Protease
Source: ChEMBL
Protein Target: Pol polyprotein
Substance BioActivity: 44 Active, 3 Activity <= 1 nM, 39 Activity <= 1 µM, 46 Tested
AID: 161735

535. Inhibitory activity against HIV-1 Protease
Source: ChEMBL
Protein Target: Pol polyprotein
Substance BioActivity: 7 Active, 7 Activity <= 1 µM, 7 Tested
AID: 161734

536. Ability to prevent cleavage of acompound by the HIV protease wild-type enzyme
Source: ChEMBL
Protein Target: Pol polyprotein
Substance BioActivity: 4 Active, 4 Activity <= 1 nM, 4 Activity <= 1 µM, 4 Tested
AID: 162028

537. Inhibitory activity was evaluated against HIV-protease was evaluated
Source: ChEMBL
Protein Target: Pol polyprotein
Substance BioActivity: 1 Active, 1 Activity <= 1 µM, 1 Tested
AID: 162366

538. Inhibitory concentration required to inhibit hydrolytic activity of recombinant HIV-1 PR (human immunodeficiency virus protease)
Source: ChEMBL
Protein Target: Pol polyprotein
Substance BioActivity: 1 Active, 1 Activity <= 1 µM, 3 Tested
AID: 82301

539. Inhibition of HIV-1 Mutant HIV-1 RT enzymes containing the single amino acid substitution V179D
Source: ChEMBL
Protein Target: Pol polyprotein
Substance BioActivity: 2 Active, 2 Activity <= 1 µM, 2 Tested
AID: 198914

540. Anti-HIV-1 activity determined in human peripheral blood mononuclear PBM cells, expressed as EC50
Source: ChEMBL
Protein Target: Pol polyprotein
Substance BioActivity: 6 Active, 2 Activity <= 1 µM, 27 Tested
AID: 154957

541. Activity to inhibit mutant HIV-1 rRT activity in Y181C
Source: ChEMBL
Protein Target: Pol polyprotein
Substance BioActivity: 3 Active, 3 Activity <= 1 µM, 3 Tested
AID: 80893

542. Compound was tested in vitro to inhibit human immuno virus-1 (HIV-1) using enzymatic disintegration assay.
Source: ChEMBL
Protein Target: Pol polyprotein
Substance BioActivity: 3 Active, 4 Tested
AID: 93390

543. Inhibition of strand -transfer (ST) activity in the presence of Mn2+
Source: ChEMBL
Protein Target: Pol polyprotein
Substance BioActivity: 9 Active, 1 Activity <= 1 µM, 17 Tested
AID: 93367

544. Tested in vitro against strand -transfer (ST) activity in the presence of Mg2+ as the cationic cofactor
Source: ChEMBL
Protein Target: Pol polyprotein
Substance BioActivity: 5 Active, 13 Tested
AID: 93366

545. Inhibition of 3'-processing (TC) in the presence of Mn2+ in vitro
Source: ChEMBL
Protein Target: Pol polyprotein
Substance BioActivity: 10 Active, 17 Tested
AID: 93365

546. Inhibitory activity against TIBO-resistant HIV-1 RT Nucleic Acid polymerase
Source: ChEMBL
Protein Target: Pol polyprotein
Substance BioActivity: 2 Active, 2 Tested
AID: 199680

547. Inhibitory activity against RNA-dependent DNA polymerase (RDDP) of HIV-1 RT Nucleic Acid polymerase
Source: ChEMBL
Protein Target: Pol polyprotein
Substance BioActivity: 3 Active, 2 Activity <= 1 µM, 3 Tested
AID: 199679

548. Inhibitory activity against DNA -dependent DNA polymerase (DDDP) of HIV-1 RT Nucleic Acid polymerase
Source: ChEMBL
Protein Target: Pol polyprotein
Substance BioActivity: 2 Active, 2 Activity <= 1 µM, 3 Tested
AID: 199678

549. Compound was tested for Inhibition of HIV-1 RT activity
Source: ChEMBL
Protein Target: Pol polyprotein
Substance BioActivity: 1 Active, 1 Activity <= 1 µM, 1 Tested
AID: 197791

550. Compound is evaluated in vitro for the inhibition single mutant of HIV-1 RTS (Y181C)
Source: ChEMBL
Protein Target: Pol polyprotein
Substance BioActivity: 1 Active, 1 Activity <= 1 µM, 1 Tested
AID: 200173

551. Compound is evaluated in vitro for the inhibition single mutant of HIV-1 RTS (K103 N)
Source: ChEMBL
Protein Target: Pol polyprotein
Substance BioActivity: 1 Active, 1 Activity <= 1 µM, 1 Tested
AID: 200172

552. Inhibition single mutant of HIV-1 RT (Y181C)
Source: ChEMBL
Protein Target: Pol polyprotein
Substance BioActivity: 6 Active, 1 Activity <= 1 µM, 7 Tested
AID: 200171

553. Inhibition single mutant of HIV-1 RT (K103 N)
Source: ChEMBL
Protein Target: Pol polyprotein
Substance BioActivity: 6 Active, 2 Activity <= 1 µM, 7 Tested
AID: 200170

554. Inhibition of HIV-1 RT using rC-dG as template
Source: ChEMBL
Protein Target: Pol polyprotein
Substance BioActivity: 13 Active, 11 Activity <= 1 µM, 15 Tested
AID: 200169

555. Inhibitory effect on HIV-1 RT activity using template primer,poly (rC)-oligo (dG)
Source: ChEMBL
Protein Target: Pol polyprotein
Substance BioActivity: 2 Active, 2 Activity <= 1 µM, 2 Tested
AID: 198388

556. Inhibitory effect on HIV-1 RT activity using template primer,poly (rA)-oligo (dT)
Source: ChEMBL
Protein Target: Pol polyprotein
Substance BioActivity: 5 Active, 1 Activity <= 1 µM, 5 Tested
AID: 198387

557. IC50 value was measured as RNA dependent DNA polymerase associated activity by using 1*10e-3 units of radiolabeled template poly(rC)-oligo(dG)
Source: ChEMBL
Protein Target: Pol polyprotein
Substance BioActivity: 1 Active, 1 Tested
AID: 197940

558. IC50 value was measured as RNA dependent DNA polymerase associated activity by using 1*10e-3 units of radiolabeled template poly(rA)-oligo(dT)
Source: ChEMBL
Protein Target: Pol polyprotein
Substance BioActivity: 1 Active, 1 Tested
AID: 197939

559. IC50 value was measured as RNA dependent DNA polymerase associated activity by using 10e-3 units of radiolabeled template poly(rC)-oligo(dG).
Source: ChEMBL
Protein Target: Pol polyprotein
Substance BioActivity: 1 Active, 1 Tested
AID: 197938

560. IC50 value was measured as RNA dependent DNA polymerase associated activity by using 10e-3 units of radiolabeled template poly(rA)-oligo(dT).
Source: ChEMBL
Protein Target: Pol polyprotein
Substance BioActivity: 1 Active, 1 Tested
AID: 197937

561. IC50 value was measured as DNA dependent DNA polymerase associated activity by using 0.05 units of radiolabeled template poly(rA)-oligo(dT).
Source: ChEMBL
Protein Target: Pol polyprotein
Substance BioActivity: 1 Active, 1 Activity <= 1 µM, 1 Tested
AID: 197936

562. IC50 value was measured as DNA dependent DNA polymerase associated activity by using 0.05 units of radiolabeled template poly(rA)-oligo(dT)
Source: ChEMBL
Protein Target: Pol polyprotein
Substance BioActivity: 1 Active, 1 Activity <= 1 µM, 1 Tested
AID: 197935

563. In vitro inhibitory activity against HIV proteinase
Source: ChEMBL
Protein Target: Pol polyprotein
Substance BioActivity: 31 Active, 1 Activity <= 1 nM, 24 Activity <= 1 µM, 34 Tested
AID: 162047

564. Compound is evaluated in vitro for the inhibition single mutant of HIV-1 RT (K103 N)
Source: ChEMBL
Protein Target: Pol polyprotein
Substance BioActivity: 1 Active, 1 Tested
AID: 94311

565. Compound is evaluated in vitro for the inhibition single mutant of HIV-1 RT (Y181C)
Source: ChEMBL
Protein Target: Pol polyprotein
Substance BioActivity: 1 Active, 1 Tested
AID: 3047

566. Binding affinity against HIV-1 aspartic proteinase was determined
Source: ChEMBL
Protein Target: Pol polyprotein
Substance BioActivity: 4 Active, 2 Activity <= 1 nM, 4 Activity <= 1 µM, 4 Tested
AID: 162713

567. Compound was evaluated for its ability to inhibit the mutant K103N V1081NNRTI HIV-1 enzyme
Source: ChEMBL
Protein Target: Pol polyprotein
Substance BioActivity: 4 Active, 3 Activity <= 1 µM, 4 Tested
AID: 143402

568. Compound was evaluated for its ability to inhibit the mutant K103N P225H NNRTI HIV-1 enzyme
Source: ChEMBL
Protein Target: Pol polyprotein
Substance BioActivity: 4 Active, 4 Activity <= 1 µM, 4 Tested
AID: 143399

569. Compound was evaluated for its ability to inhibit the mutant K103N NNRTI HIV-1 enzyme
Source: ChEMBL
Protein Target: Pol polyprotein
Substance BioActivity: 6 Active, 6 Activity <= 1 µM, 6 Tested
AID: 143398

570. Compound was evaluated for its ability to inhibit the mutant K103N L1001 NNRTI HIV-1 enzyme
Source: ChEMBL
Protein Target: Pol polyprotein
Substance BioActivity: 4 Active, 1 Activity <= 1 µM, 4 Tested
AID: 143396

571. Compound was evaluated for its ability to inhibit the NNRTI HIV-1 enzyme by 90% using whole cell assay
Source: ChEMBL
Protein Target: Pol polyprotein
Substance BioActivity: 2 Active, 2 Activity <= 1 µM, 2 Tested
AID: 143394

572. Compound was evaluated for its ability to inhibit the NNRTI HIV-1 enzyme by 50% using enzyme assay
Source: ChEMBL
Protein Target: Pol polyprotein
Substance BioActivity: 1 Active, 1 Activity <= 1 µM, 1 Tested
AID: 143392

573. Inhibitory concentration against wild-type virus K103N/L1001 and HIVdouble mutant in a whole cell antiviral assay
Source: ChEMBL
Protein Target: Pol polyprotein
Substance BioActivity: 1 Active, 1 Tested
AID: 94450

574. Inhibitory concentration against wild-type virus K103N/L1001 and HIV-1 RT double mutant in whole cell antiviral assay
Source: ChEMBL
Protein Target: Pol polyprotein
Substance BioActivity: 11 Active, 3 Activity <= 1 µM, 11 Tested
AID: 94449

575. Inhibitory concentration against wild-type virus K103N mutant in a whole cell antiviral assay
Source: ChEMBL
Protein Target: Pol polyprotein
Substance BioActivity: 1 Active, 1 Activity <= 1 µM, 1 Tested
AID: 94448

576. Inhibitory concentration against polymerization in A17 double mutant HIV-1 RT using a template primer of poly rC/dG12-18 and [3H]dGTP
Source: ChEMBL
Protein Target: Pol polyprotein
Substance BioActivity: 3 Active, 7 Tested
AID: 83433

577. Inhibitory activity against HIV-1 RT with poly.rC-oligo.dG template primer
Source: ChEMBL
Protein Target: Pol polyprotein
Substance BioActivity: 13 Active, 11 Activity <= 1 µM, 13 Tested
AID: 198082

578. The compound was tested in vitro for its inhibitory activity against HIV-1 Proteinase activity
Source: ChEMBL
Protein Target: Pol polyprotein
Substance BioActivity: 10 Active, 1 Activity <= 1 nM, 10 Activity <= 1 µM, 10 Tested
AID: 165346

579. Inhibitory activity against HIV-1 proteinase
Source: ChEMBL
Protein Target: Pol polyprotein
Substance BioActivity: 3 Active, 2 Activity <= 1 µM, 5 Tested
AID: 165345

580. Concentration that inhibits cellular growth of MT-4 cells acutely infected with HIV-1 RFstrain by 50%
Source: ChEMBL
Protein Target: Pol polyprotein
Substance BioActivity: 15 Active, 15 Activity <= 1 µM, 20 Tested
AID: 105579

581. Cytotoxic activity was determined against HIV-1 infected MT-4 cells.
Source: ChEMBL
Protein Target: Pol polyprotein
Substance BioActivity: 12 Active, 20 Tested
AID: 105374

582. Inhibitory activity against HIV-1 RF infected MT-2 cells
Source: ChEMBL
Protein Target: Pol polyprotein
Substance BioActivity: 21 Active, 13 Activity <= 1 µM, 22 Tested
AID: 104394
